<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Biochem</journal-id><journal-title>BMC Biochemistry</journal-title><issn pub-type="epub">1471-2091</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1471-2091-8-3</article-id><article-id pub-id-type="pmid">17374145</article-id><article-id pub-id-type="doi">10.1186/1471-2091-8-3</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Kinetic characterisation of arylamine <italic>N</italic>-acetyltransferase from <italic>Pseudomonas aeruginosa</italic></article-title></title-group><contrib-group><contrib id="A1" contrib-type="author"><name><surname>Westwood</surname><given-names>Isaac M</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>isaac.westwood@pharm.ox.ac.uk</email></contrib><contrib id="A2" corresp="yes" contrib-type="author"><name><surname>Sim</surname><given-names>Edith</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>edith.sim@pharm.ox.ac.uk</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Pharmacology, University of Oxford, Mansfield Road, Oxford, UK</aff><pub-date pub-type="collection"><year>2007</year></pub-date><pub-date pub-type="epub"><day>20</day><month>3</month><year>2007</year></pub-date><volume>8</volume><fpage>3</fpage><lpage>3</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2091/8/3"/><history><date date-type="received"><day>14</day><month>11</month><year>2006</year></date><date date-type="accepted"><day>20</day><month>3</month><year>2007</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2007 Westwood and Sim; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2007</copyright-year><copyright-holder>Westwood and Sim; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author> Westwood M Isaac isaac.westwood@pharm.ox.ac.uk </dc:author><dc:title> Kinetic characterisation of arylamine N-acetyltransferase from Pseudomonas aeruginosa </dc:title><dc:date>2007</dc:date><dcterms:bibliographicCitation>BMC Biochemistry 8(1): 3-. (2007)</dcterms:bibliographicCitation><dc:identifier type="sici">1471-2091(2007)8:1&#x0003c;3&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1471-2091</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p>Arylamine <italic>N</italic>-acetyltransferases (NATs) are important drug- and carcinogen-metabolising enzymes that catalyse the transfer of an acetyl group from a donor, such as acetyl coenzyme A, to an aromatic or heterocyclic amine, hydrazine, hydrazide or <italic>N</italic>-hydroxylamine acceptor substrate. NATs are found in eukaryotes and prokaryotes, and they may also have an endogenous function in addition to drug metabolism. For example, NAT from <italic>Mycobacterium tuberculosis </italic>has been proposed to have a role in cell wall lipid biosynthesis, and is therefore of interest as a potential drug target. To date there have been no studies investigating the kinetic mechanism of a bacterial NAT enzyme.</p></sec><sec><title>Results</title><p>We have determined that NAT from <italic>Pseudomonas aeruginosa</italic>, which has been described as a model for NAT from <italic>M. tuberculosis</italic>, follows a Ping Pong Bi Bi kinetic mechanism. We also describe substrate inhibition by 5-aminosalicylic acid, in which the substrate binds both to the free form of the enzyme and the acetyl coenzyme A-enzyme complex in non-productive reaction pathways. The true kinetic parameters for the NAT-catalysed acetylation of 5-aminosalicylic acid with acetyl coenzyme A as the co-factor have been established, validating earlier approximations.</p></sec><sec><title>Conclusion</title><p>This is the first reported study investigating the kinetic mechanism of a bacterial NAT enzyme. Additionally, the methods used herein can be applied to investigations of the interactions of NAT enzymes with new chemical entities which are NAT ligands. This is likely to be useful in the design of novel potential anti-tubercular agents.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>Arylamine <italic>N</italic>-acetyltransferases (NATs, E.C. 2.3.1.5) are a family of enzymes (30&#x02013;34 kDa) found in a range of eukaryotes and prokaryotes. NATs catalyse the transfer of an acetyl group from a donor, such as acetyl coenzyme A (AcCoA) to an aromatic or heterocyclic amine, hydrazine, hydrazide or <italic>N</italic>-hydroxylamine acceptor substrate.</p><p>The NAT enzymes in prokaryotes, particularly NAT from <italic>S. typhimurium </italic>[<xref ref-type="bibr" rid="B1">1</xref>], have been important in studies of the metabolism of carcinogens. Recent evidence suggests that prokaryotic NATs may also have an endogenous role. For example, a NAT-like protein in <italic>Amycolatopsis mediterranei </italic>(RifF) is responsible for the final ring-closure step in the biosynthesis of the rifamycin precursor, proansamycin X [<xref ref-type="bibr" rid="B2">2</xref>]. Although the precise endogenous function of NAT in mycobacteria has not been established, genetic studies suggest strongly that NAT has a role in cell wall complex lipid biosynthesis in <italic>Mycobacterium bovis </italic>BCG [<xref ref-type="bibr" rid="B3">3</xref>]. It has been proposed that NAT represents a good anti-tubercular target, since ablation of the <italic>nat </italic>gene results in increased intracellular killing of mycobacteria within macrophage [<xref ref-type="bibr" rid="B3">3</xref>]. The NAT from <italic>Mycobacterium tuberculosis </italic>has not been expressed as a soluble recombinant enzyme in sufficient quantities for detailed activity studies, although other bacterial NATs are available. These include NATs from <italic>Salmonella typhimurium </italic>[<xref ref-type="bibr" rid="B4">4</xref>], <italic>Mycobacterium smegmatis </italic>[<xref ref-type="bibr" rid="B5">5</xref>], <italic>Mesorhizobium loti </italic>[<xref ref-type="bibr" rid="B6">6</xref>] and <italic>Pseudomonas aeruginosa </italic>[<xref ref-type="bibr" rid="B7">7</xref>]. The three-dimensional structures of these enzymes have been solved by X-ray crystallography. The overall fold is superimposable [<xref ref-type="bibr" rid="B6">6</xref>-<xref ref-type="bibr" rid="B9">9</xref>], and all four enzymes share a catalytic triad of residues: Cys-His-Asp [<xref ref-type="bibr" rid="B9">9</xref>], a motif which is completely conserved throughout all known active NATs [<xref ref-type="bibr" rid="B10">10</xref>].</p><p>As a start to the process of identifying novel NAT ligands, Brooke and others have developed a method suitable for the rapid identification of NAT substrates and inhibitors with the colorimetric agent 5,5'-dithio-bis(2-nitrobenzoic acid) (Ellman's reagent, DTNB) [<xref ref-type="bibr" rid="B11">11</xref>]. The extent of reaction is measured by detecting the coloured 5-thio-2-nitrobenzoic acid, produced by reaction of DTNB with the free thiol CoA, formed during the NAT reaction [<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B12">12</xref>]. Brooke and co-workers have used this method to identify novel inhibitors of bacterial NATs with the aim of developing novel antimycobacterial agents [<xref ref-type="bibr" rid="B13">13</xref>]. While the structures of bacterial NATs are known, to date, there have been no kinetic analyses of prokaryotic NAT enzymes and it is not known whether these enzymes share the kinetic mechanism previously determined for their eukaryotic counterparts.</p><p>The eukaryotic NAT enzymes have been investigated in relation to their role in drug- and carcinogen-metabolism [<xref ref-type="bibr" rid="B14">14</xref>-<xref ref-type="bibr" rid="B16">16</xref>], and it has also been suggested that certain eukaryotic NATs have an endogenous role [<xref ref-type="bibr" rid="B17">17</xref>]. The crystal structure of human NAT1 (F125S mutant, pdb code 2IJA) has recently been solved. This crystal structure, along with an NMR-derived model of human NAT1 [<xref ref-type="bibr" rid="B18">18</xref>] and homology models of human NAT1 [<xref ref-type="bibr" rid="B19">19</xref>], human NAT2 [<xref ref-type="bibr" rid="B20">20</xref>] and hamster NAT2 [<xref ref-type="bibr" rid="B21">21</xref>], all show that the three-dimensional fold is very highly conserved throughout the NAT family, with very similar positioning of the catalytic triad residues. The most notable difference between eukaryotic and prokaryotic NATs is the existence of a loop region between the second and third domains in eukaryotic NATs, which is unlikely to have a role in catalysis [<xref ref-type="bibr" rid="B21">21</xref>,<xref ref-type="bibr" rid="B22">22</xref>].</p><p>The determination of kinetic constants for NAT, in particular with AcCoA as the acetyl donor, is experimentally challenging [<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B24">24</xref>]. The apparent Michaelis constants and limiting rates of <italic>N</italic>-acetylation are dependent on the concentrations of the acetyl donor and acceptor. There are several features of the reactants which limit the determination of kinetic parameters by linear methods, including limited solubility and very high optical absorbance. Despite the technical difficulties associated with NAT enzyme assays, the enzymatic reactions of NATs from pigeon liver [<xref ref-type="bibr" rid="B25">25</xref>] and rabbit liver [<xref ref-type="bibr" rid="B26">26</xref>] preparations have been shown to follow the Ping Pong Bi Bi kinetic mechanism [<xref ref-type="bibr" rid="B27">27</xref>]. Approximate kinetic parameters have been determined for several eukaryotic NAT enzymes [<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B28">28</xref>-<xref ref-type="bibr" rid="B33">33</xref>], and Wagner, Hanna and colleagues have recently determined the catalytic mechanism of pure recombinant NAT2 from Syrian hamsters [<xref ref-type="bibr" rid="B34">34</xref>,<xref ref-type="bibr" rid="B35">35</xref>]. No such analysis has been carried out so far for any of the bacterial NATs.</p><p>The NAT enzyme from <italic>P</italic>. <italic>aeruginosa </italic>(PANAT) has been cloned, expressed, characterised and crystallised [<xref ref-type="bibr" rid="B7">7</xref>], and is an ideal enzyme system for the study of the kinetics of a bacterial member of this unique enzyme family. The PANAT enzyme is very stable and highly active relative to other bacterial NATs currently available as pure proteins [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B7">7</xref>].</p></sec><sec><title>Results</title><sec><title>Determination of the kinetic mechanism and true kinetic parameters by normalised plot analysis</title><p>We have used a normalised plot method, described by Bravo and colleagues [<xref ref-type="bibr" rid="B36">36</xref>], to elucidate the kinetic mechanism of the PANAT-catalysed <italic>N</italic>-acetylation of 5-aminosalicylic acid with AcCoA as acetyl donor, and to measure the true kinetic parameters for the substrates.</p><p>A flowchart describing the normalised plot method is presented as supplemental data [see Additional file <xref ref-type="supplementary-material" rid="S1">1</xref>]. In this method, the normalised concentration (<italic>A</italic>') is defined as an arbitrary constant concentration (<italic>A</italic>) multiplied by a numerical factor (<italic>a</italic>) as shown in equation 1.</p><p><italic>A</italic>' = <italic>aA </italic>&#x000a0;&#x000a0;&#x000a0; <bold>(1)</bold></p><p>The initial rates of reaction are measured in three separate experimental series. For the series <italic>b </italic>= 1, reaction velocities (<italic>V</italic><sub><italic>a</italic>,<italic>b</italic></sub>) are measured in the presence of a constant concentration of 5-aminosalicylic acid (<italic>B</italic>), and a series of actual concentrations of AcCoA which are described as multiples of the arbitrarily fixed concentration <italic>A </italic>(e.g. for a concentration of <inline-formula><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1" name="1471-2091-8-3-i1" overflow="scroll"><mml:semantics definitionURL="" encoding=""><mml:mrow><mml:mfrac><mml:mi>A</mml:mi><mml:mn>4</mml:mn></mml:mfrac></mml:mrow><mml:annotation encoding="MathType-MTEF"> MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaadaWcaaqaaiabdgeabbqaaiabisda0aaaaaa@2EBD@</mml:annotation></mml:semantics></mml:math></inline-formula>, <italic>a </italic>= 0.25). Similarly, for the series <italic>a </italic>= 1, <italic>V</italic><sub><italic>a</italic>,<italic>b </italic></sub>values are measured in the presence of AcCoA (at concentration <italic>A</italic>) and a series of concentrations of 5-aminosalicylic acid (multiples of <italic>B</italic>). For the final series of data (<italic>a </italic>= <italic>b</italic>), the concentrations of substrates are varied in identical proportions (e.g. <inline-formula><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M2" name="1471-2091-8-3-i1" overflow="scroll"><mml:semantics definitionURL="" encoding=""><mml:mrow><mml:mfrac><mml:mi>A</mml:mi><mml:mn>4</mml:mn></mml:mfrac></mml:mrow><mml:annotation encoding="MathType-MTEF"> MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaadaWcaaqaaiabdgeabbqaaiabisda0aaaaaa@2EBD@</mml:annotation></mml:semantics></mml:math></inline-formula> and <inline-formula><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M3" name="1471-2091-8-3-i2" overflow="scroll"><mml:semantics definitionURL="" encoding=""><mml:mrow><mml:mfrac><mml:mi>B</mml:mi><mml:mn>4</mml:mn></mml:mfrac></mml:mrow><mml:annotation encoding="MathType-MTEF"> MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaadaWcaaqaaiabdkeacbqaaiabisda0aaaaaa@2EBF@</mml:annotation></mml:semantics></mml:math></inline-formula>, <inline-formula><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M4" name="1471-2091-8-3-i3" overflow="scroll"><mml:semantics definitionURL="" encoding=""><mml:mrow><mml:mfrac><mml:mi>A</mml:mi><mml:mn>2</mml:mn></mml:mfrac></mml:mrow><mml:annotation encoding="MathType-MTEF"> MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaadaWcaaqaaiabdgeabbqaaiabikdaYaaaaaa@2EB9@</mml:annotation></mml:semantics></mml:math></inline-formula> and <inline-formula><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M5" name="1471-2091-8-3-i4" overflow="scroll"><mml:semantics definitionURL="" encoding=""><mml:mrow><mml:mfrac><mml:mi>B</mml:mi><mml:mn>2</mml:mn></mml:mfrac></mml:mrow><mml:annotation encoding="MathType-MTEF"> MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaadaWcaaqaaiabdkeacbqaaiabikdaYaaaaaa@2EBB@</mml:annotation></mml:semantics></mml:math></inline-formula>). The experiment is designed such that the initial reaction velocity where <italic>a </italic>= <italic>b </italic>= 1 (<italic>V</italic><sub>1,1</sub>, eq. 2) is measured in each series of collected data. The normalised velocity, <inline-formula><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M6" name="1471-2091-8-3-i5" overflow="scroll"><mml:semantics definitionURL="" encoding=""><mml:mrow><mml:msub><mml:mrow><mml:mover accent="true"><mml:mi>V</mml:mi><mml:mo stretchy="true">&#x000af;</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>a</mml:mi><mml:mo>,</mml:mo><mml:mi>b</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:annotation encoding="MathType-MTEF"> MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaadaqdaaqaaiabdAfawbaadaWgaaWcbaGaemyyaeMaeiilaWIaemOyaigabeaaaaa@3196@</mml:annotation></mml:semantics></mml:math></inline-formula> (eq. 2), is a corrected reciprocal value of the experimentally determined value.</p><p><inline-formula><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M7" name="1471-2091-8-3-i6" overflow="scroll"><mml:semantics definitionURL="" encoding=""><mml:mrow><mml:msub><mml:mrow><mml:mover accent="true"><mml:mi>V</mml:mi><mml:mo stretchy="true">&#x000af;</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>a</mml:mi><mml:mo>,</mml:mo><mml:mi>b</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub></mml:mrow><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:mo>,</mml:mo><mml:mi>b</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mtext>&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;</mml:mtext><mml:mrow><mml:mo>(</mml:mo><mml:mn>2</mml:mn><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:annotation encoding="MathType-MTEF"> MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaadaqdaaqaaiabdAfawbaadaWgaaWcbaGaemyyaeMaeiilaWIaemOyaigabeaakiabg2da9maalaaabaGaemOvay1aaSbaaSqaaiabigdaXiabcYcaSiabigdaXaqabaaakeaacqWGwbGvdaWgaaWcbaGaemyyaeMaeiilaWIaemOyaigabeaaaaGccaWLjaGaaCzcamaabmaabaacbeGae8NmaidacaGLOaGaayzkaaaaaa@3F84@</mml:annotation></mml:semantics></mml:math></inline-formula></p><p>The following experiments were performed with PANAT, AcCoA (A) and 5-aminosalicylic acid (B). The arbitrarily fixed values of <italic>A </italic>and <italic>B </italic>were 0.4 mM and 0.2 mM respectively. Assays were carried out in which the factors <italic>a </italic>and <italic>b </italic>were varied in the following series: <italic>a </italic>= <italic>b </italic>(0.25 to 15), <italic>a </italic>= 1 (<italic>b </italic>= 0.25 to 15) and <italic>b </italic>= 1 (<italic>a </italic>= 0.25 to 2), and the normalised velocities were calculated from the initial rates of reaction according to equation 2. Four possible rival kinetic mechanisms have been considered: Ping Pong Bi Bi with and without substrate inhibition, and Ordered Bi Bi with and without substrate inhibition. A normalised rate equation was derived (eq. 3) with three terms (<italic>&#x003b1;</italic>, <italic>&#x003b2; </italic>and <italic>&#x003b3;</italic>, Table <xref ref-type="table" rid="T1">1</xref>), which, when included in different combinations, allow these four possible rival kinetic models to be described (Table <xref ref-type="table" rid="T2">2</xref>). The definitions of <italic>&#x003b1;</italic>, <italic>&#x003b2;</italic>, <italic>&#x003b3; </italic>and <italic>den </italic>are given in Table <xref ref-type="table" rid="T1">1</xref>.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Definitions of parameters in the normalised velocity equation (eq 3)<sup>a</sup></p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center">Parameter<sup><italic>b</italic></sup></td><td align="center">Definition<sup><italic>c</italic></sup></td><td align="center">Comments</td></tr></thead><tbody><tr><td align="center"><italic>&#x003b1;</italic></td><td align="center"><italic>K</italic><sub>iB</sub><italic>K</italic><sub>mA</sub></td><td align="center">Appears in Ordered Bi Bi only</td></tr><tr><td align="center"><italic>&#x003b2;</italic></td><td align="center"><inline-formula><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M8" name="1471-2091-8-3-i7" overflow="scroll"><mml:semantics definitionURL="" encoding=""><mml:mrow><mml:mfrac><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mtext>mA</mml:mtext></mml:mrow></mml:msub><mml:msup><mml:mi>b</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:msup><mml:mi>B</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mtext>si</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mtext>B</mml:mtext><mml:mo>&#x02192;</mml:mo><mml:mtext>E</mml:mtext><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mrow><mml:annotation encoding="MathType-MTEF"> MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaadaWcaaqaaiabdUealnaaBaaaleaacqqGTbqBcqqGbbqqaeqaaOGaemOyai2aaWbaaSqabeaacqaIYaGmaaGccqWGcbGqdaahaaWcbeqaaiabikdaYaaaaOqaaiabdUealnaaBaaaleaacqqGZbWCcqqGPbqAcqGGOaakcqqGcbGqcqGHsgIRcqqGfbqrcqGGPaqkaeqaaaaaaaa@3EF3@</mml:annotation></mml:semantics></mml:math></inline-formula></td><td align="center">Accounts for substrate inhibition by 5-aminosalicylic acid on the free enzyme</td></tr><tr><td align="center"><italic>&#x003b3;</italic></td><td align="center"><inline-formula><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M9" name="1471-2091-8-3-i8" overflow="scroll"><mml:semantics definitionURL="" encoding=""><mml:mrow><mml:mfrac><mml:mrow><mml:mi>a</mml:mi><mml:mi>A</mml:mi><mml:msup><mml:mi>b</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:msup><mml:mi>B</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mtext>si</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mtext>B</mml:mtext><mml:msubsup><mml:mo>&#x02192;</mml:mo><mml:mrow><mml:mtext>FP</mml:mtext></mml:mrow><mml:mrow><mml:mtext>EA</mml:mtext></mml:mrow></mml:msubsup><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mrow><mml:annotation encoding="MathType-MTEF"> MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaadaWcaaqaaiabdggaHjabdgeabjabdkgaInaaCaaaleqabaGaeGOmaidaaOGaemOqai0aaWbaaSqabeaacqaIYaGmaaaakeaacqWGlbWsdaWgaaWcbaGaee4CamNaeeyAaKMaeiikaGIaeeOqaiKaeyOKH46aa0baaWqaaiabbAeagjabbcfaqbqaaiabbweafjabbgeabbaaliabcMcaPaqabaaaaaaa@4106@</mml:annotation></mml:semantics></mml:math></inline-formula></td><td align="center">Accounts for substrate inhibition by 5-aminosalicylic acid on the enzyme&#x000b7;AcCoA complex</td></tr><tr><td align="center"><italic>den</italic></td><td align="center"><inline-formula><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M10" name="1471-2091-8-3-i9" overflow="scroll"><mml:semantics definitionURL="" encoding=""><mml:mrow><mml:mi>&#x003b1;</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mtext>mB</mml:mtext></mml:mrow></mml:msub><mml:mi>A</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mtext>mA</mml:mtext></mml:mrow></mml:msub><mml:mi>B</mml:mi><mml:mo>+</mml:mo><mml:mi>A</mml:mi><mml:mi>B</mml:mi><mml:mo>+</mml:mo><mml:mfrac><mml:mi>&#x003b2;</mml:mi><mml:mrow><mml:msup><mml:mi>b</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mi>&#x003b3;</mml:mi><mml:mrow><mml:mi>a</mml:mi><mml:msup><mml:mi>b</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:mfrac></mml:mrow><mml:annotation encoding="MathType-MTEF"> MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaaiiGacqWFXoqycqGHRaWkcqWGlbWsdaWgaaWcbaGaeeyBa0MaeeOqaieabeaakiabdgeabjabgUcaRiabdUealnaaBaaaleaacqqGTbqBcqqGbbqqaeqaaOGaemOqaiKaey4kaSIaemyqaeKaemOqaiKaey4kaSYaaSaaaeaacqWFYoGyaeaacqWGIbGydaahaaWcbeqaaiabikdaYaaaaaGccqGHRaWkdaWcaaqaaiab=n7aNbqaaiabdggaHjabdkgaInaaCaaaleqabaGaeGOmaidaaaaaaaa@47F7@</mml:annotation></mml:semantics></mml:math></inline-formula></td><td align="center">The denominator term <italic>den </italic>is independent of both <italic>a </italic>and <italic>b</italic></td></tr></tbody></table><table-wrap-foot><p><sup><italic>a </italic></sup>The parameters <italic>&#x003b1;</italic>, <italic>&#x003b2; </italic>and <italic>&#x003b3; </italic>are set to zero in different combinations to define different mechanisms.</p><p><sup><italic>b </italic></sup>The definition of <italic>&#x003b3; </italic>given here is for the Ping Pong Bi Bi mechanism (in which <italic>&#x003b1; </italic>= 0). <italic>&#x003b3; </italic>for the Ordered Bi Bi mechanism is similar, however the denominator would be <inline-formula><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M11" name="1471-2091-8-3-i10" overflow="scroll"><mml:semantics definitionURL="" encoding=""><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mtext>si</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mtext>B</mml:mtext><mml:msubsup><mml:mo>&#x02192;</mml:mo><mml:mrow><mml:mtext>EPQ</mml:mtext></mml:mrow><mml:mrow><mml:mtext>EAB</mml:mtext></mml:mrow></mml:msubsup><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msub></mml:mrow><mml:annotation encoding="MathType-MTEF"> MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacqWGlbWsdaWgaaWcbaGaee4CamNaeeyAaKMaeiikaGIaeeOqaiKaeyOKH46aa0baaWqaaiabbweafjabbcfaqjabbgfarbqaaiabbweafjabbgeabjabbkeacbaaliabcMcaPaqabaaaaa@3C26@</mml:annotation></mml:semantics></mml:math></inline-formula>, relating to the binding of 5-aminosalicylic acid to either of the trimolecular EAB or EPQ complexes.</p><p><sup><italic>c </italic></sup>The <italic>K</italic><sub>i </sub>and <italic>K</italic><sub>si </sub>terms are true dissociation constants for the enzyme&#x000b7;substrate complexes indicated, and <italic>K</italic><sub>m </sub>values are Michaelis constants for the substrates indicated.</p></table-wrap-foot></table-wrap><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Results of non-linear regression by the least-squares method.<sup>a</sup></p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center">Mechanism<sup><italic>b</italic></sup></td><td align="center">1</td><td align="center">2</td><td align="center">3</td><td align="center">4</td></tr></thead><tbody><tr><td align="center">Constant<sup><italic>c</italic></sup></td><td align="center"><italic>&#x003b1; </italic>= 0</td><td align="center"><italic>&#x003b1; </italic>= <italic>&#x003b2; </italic>= 0</td><td></td><td align="center"><italic>&#x003b2; </italic>= 0</td></tr><tr><td colspan="5"><hr></hr></td></tr><tr><td align="center"><italic>K</italic><sub>mB</sub></td><td align="center">0.219 &#x000b1; 0.073**</td><td align="center">0.199 &#x000b1; 0.174<sup>&#x02020;</sup></td><td align="center">0.219 &#x000b1; 0.120<sup>&#x02020;</sup></td><td align="center">0.199 &#x000b1; 0.279<sup>&#x02020;</sup></td></tr><tr><td align="center"><italic>K</italic><sub>mA</sub></td><td align="center">1.02 &#x000b1; 0.29**</td><td align="center">1.51 &#x000b1; 1.03<sup>&#x02020;</sup></td><td align="center">1.02 &#x000b1; 0.46*</td><td align="center">1.51 &#x000b1; 1.53<sup>&#x02020;</sup></td></tr><tr><td align="center"><italic>K</italic><sub>si(B&#x02192;E)</sub></td><td align="center">1.93 &#x000b1; 0.28***</td><td align="center">-</td><td align="center">1.93 &#x000b1; 0.37***</td><td align="center">-</td></tr><tr><td align="center"><inline-formula><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M12" name="1471-2091-8-3-i11" overflow="scroll"><mml:semantics definitionURL="" encoding=""><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mtext>si</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mtext>B</mml:mtext><mml:msubsup><mml:mo>&#x02192;</mml:mo><mml:mrow><mml:mtext>FP</mml:mtext></mml:mrow><mml:mrow><mml:mtext>EA</mml:mtext></mml:mrow></mml:msubsup><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msub></mml:mrow><mml:annotation encoding="MathType-MTEF"> MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacqWGlbWsdaWgaaWcbaGaee4CamNaeeyAaKMaeiikaGIaeeOqaiKaeyOKH46aa0baaWqaaiabbAeagjabbcfaqbqaaiabbweafjabbgeabbaaliabcMcaPaqabaaaaa@39F4@</mml:annotation></mml:semantics></mml:math></inline-formula></td><td align="center">1.03 &#x000b1; 0.34**</td><td align="center">0.550 &#x000b1; 0.403<sup>&#x02020;</sup></td><td align="center">1.03 &#x000b1; 0.50<sup>&#x02020;</sup></td><td align="center">0.550 &#x000b1; 0.560<sup>&#x02020;</sup></td></tr><tr><td align="center"><italic>K</italic><sub>iB</sub></td><td align="center">-</td><td align="center">-</td><td align="center">~0.00 &#x000b1; 0.01<sup>&#x02020;</sup></td><td align="center">~0.00 &#x000b1; 0.01<sup>&#x02020;</sup></td></tr><tr><td align="center"><italic>den</italic></td><td align="center">0.422 &#x000b1; 0.105***</td><td align="center">0.512 &#x000b1; 0.327<sup>&#x02020;</sup></td><td align="center">0.422 &#x000b1; 0.156*</td><td align="center">0.512 &#x000b1; 0.463<sup>&#x02020;</sup></td></tr><tr><td align="center"><italic>den</italic><sub>(calc)</sub></td><td align="center">0.408</td><td align="center">0.491</td><td align="center">0.408</td><td align="center">0.491</td></tr><tr><td align="center">Sum of squares</td><td align="center">0.268</td><td align="center">1.254</td><td align="center">0.268</td><td align="center">1.254</td></tr><tr><td align="center">Bi Bi Mechanism</td><td align="center">Ping Pong</td><td align="center">Ping Pong</td><td align="center">Ordered</td><td align="center">Ordered</td></tr><tr><td align="center">Substrate inhibition by 5-aminosalicylic acid on free enzyme?</td><td align="center">Yes</td><td align="center">No</td><td align="center">Yes</td><td align="center">No</td></tr></tbody></table><table-wrap-foot><p><sup><italic>a </italic></sup>Least-squares non-linear regression was performed by using KyPlot [45].</p><p><sup><italic>b </italic></sup>Mechanisms 1 and 2 refer to Ping Pong Bi Bi kinetics allowing 5-aminosalicylic acid to act as an inhibitor of the enzyme&#x000b7;AcCoA complex (EA). Mechanism 1 also accounts for 5-aminosalicylic acid binding to the free enzyme (E). Mechanisms 3 and 4 are directly analogous to 1 and 2 respectively, however they refer to Ordered Bi Bi kinetics.</p><p><sup><italic>c </italic></sup><italic>K </italic>values have dimensions of mM and <italic>den </italic>values are expressed in mM<sup>2</sup>. <italic>&#x003b1; </italic>and <italic>&#x003b2; </italic>are defined in Table 1. Variance and statistical significance values were determined within KyPlot by Student's t test. <sup>&#x02020;</sup>, P &#x0003e;= 0.05; *, P &#x0003c; 0.05; **, P &#x0003c; 0.01; ***, P &#x0003c; 0.001.</p></table-wrap-foot></table-wrap><p><inline-formula><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M13" name="1471-2091-8-3-i12" overflow="scroll"><mml:semantics definitionURL="" encoding=""><mml:mrow><mml:msub><mml:mrow><mml:mover accent="true"><mml:mi>V</mml:mi><mml:mo stretchy="true">&#x000af;</mml:mo></mml:mover></mml:mrow><mml:mrow><mml:mi>a</mml:mi><mml:mo>,</mml:mo><mml:mi>b</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>&#x003b1;</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mtext>mB</mml:mtext></mml:mrow></mml:msub><mml:mi>a</mml:mi><mml:mi>A</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mtext>mA</mml:mtext></mml:mrow></mml:msub><mml:mi>b</mml:mi><mml:mi>B</mml:mi><mml:mo>+</mml:mo><mml:mi>a</mml:mi><mml:mi>A</mml:mi><mml:mi>b</mml:mi><mml:mi>B</mml:mi><mml:mo>+</mml:mo><mml:mi>&#x003b2;</mml:mi><mml:mo>+</mml:mo><mml:mi>&#x003b3;</mml:mi></mml:mrow><mml:mrow><mml:mi>a</mml:mi><mml:mi>b</mml:mi><mml:mo>&#x022c5;</mml:mo><mml:mi>d</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi></mml:mrow></mml:mfrac><mml:mtext>&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;</mml:mtext><mml:mrow><mml:mo>(</mml:mo><mml:mn>3</mml:mn><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:annotation encoding="MathType-MTEF"> MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaadaqdaaqaaiabdAfawbaadaWgaaWcbaGaemyyaeMaeiilaWIaemOyaigabeaakiabg2da9maalaaabaacciGae8xSdeMaey4kaSIaem4saS0aaSbaaSqaaiabb2gaTjabbkeacbqabaGccqWGHbqycqWGbbqqcqGHRaWkcqWGlbWsdaWgaaWcbaGaeeyBa0MaeeyqaeeabeaakiabdkgaIjabdkeacjabgUcaRiabdggaHjabdgeabjabdkgaIjabdkeacjabgUcaRiab=j7aIjabgUcaRiab=n7aNbqaaiabdggaHjabdkgaIjabgwSixlabdsgaKjabdwgaLjabd6gaUbaacaWLjaGaaCzcamaabmaabaWexLMBbXgBcf2CPn2qVrwzqf2zLnharyGvLjhzH5wyaGabbiaa+ndaaiaawIcacaGLPaaaaaa@63DB@</mml:annotation></mml:semantics></mml:math></inline-formula></p><p>The data shown in Figure <xref ref-type="fig" rid="F1">1</xref> were then simultaneously fitted by least-squares non-linear regression to equation 3 a total of eight times, each with different combinations of the variables <italic>&#x003b1;</italic>, <italic>&#x003b2; </italic>and <italic>&#x003b3; </italic>set to zero. When <italic>&#x003b3; </italic>was set to 0, corresponding to no inhibition by 5-aminosalicylic acid on the enzyme&#x000b7;AcCoA complex (EA) complex, no solutions could be obtained through the non-linear regression analysis. The results of non-linear regression with the remaining four combinations, corresponding to four different mechanisms, are shown in Table <xref ref-type="table" rid="T2">2</xref>. The mechanisms named 1P and 2P are Ping Pong mechanisms, and those named 3O and 4O are Ordered mechanisms. Substrate inhibition by 5-aminosalicylic acid on both the free enzyme (E) and the EA complex are accounted for by mechanisms 1P and 3O, and inhibition by 5-aminosalicylic acid on only EA is accounted for by mechanisms 2P and 4O. The self-consistency factor, <italic>den</italic>, was compared to the calculated value <italic>den</italic><sub>(calc) </sub>by using the other constants obtained from the non-linear regression analysis. The similarity of <italic>den </italic>and <italic>den</italic><sub>(calc) </sub>gives an indicator of the scientific reliability of the fit, while the sum of squares from least-squares non-linear regression indicates the mathematical accuracy of the fit [<xref ref-type="bibr" rid="B36">36</xref>].</p><fig position="float" id="F1"><label>Figure 1</label><caption><p><bold>Comparison of calculated and experimental kinetic data</bold>. The calculated and experimental normalised data for the PANAT-catalysed acetylation with the substrates AcCoA (A) and 5-aminosalicylic acid (B) is shown. The points represent the experimental data in three series: <italic>a </italic>= <italic>b </italic>(&#x025a0;), <italic>a </italic>= 1 &#x025cf;) and <italic>b </italic>= 1 (&#x025b2;), expressed as the mean &#x000b1; standard deviation of triplicate measurements. The lines represent values obtained through least-squares non-linear regression: <italic>a </italic>= <italic>b </italic>(long dashes), <italic>a </italic>= 1 (short dashes) and <italic>b </italic>= 1 (solid line). The values of the normalised substrate concentration constants <italic>A </italic>and <italic>B </italic>(eq. 1) were 0.4 and 0.2 mM respectively, and the normalised velocity is defined in equation 2. Both <italic>x</italic>- and <italic>y</italic>-coordinates are dimensionless. Reactions were performed in triplicate at 25&#x000b0;C and pH 8.0 as described in Methods.</p></caption><graphic xlink:href="1471-2091-8-3-1"/></fig><p>The Ordered Bi Bi term <italic>&#x003b1; </italic>was found to reduce to zero when included in the calculation, hence the numbers generated with equations derived for mechanisms 3O and 4O were the same as those from mechanisms 1P and 2P respectively. In all cases, the <italic>den </italic>and <italic>den</italic><sub>(calc) </sub>values were very similar; however, the sum of squares from the calculations where <italic>&#x003b2; </italic>was set to 0 were over four-fold higher than those where <italic>&#x003b2; </italic>was included. The statistical significance of each solution (determined with Student's t test within KyPlot), indicates that mechanism 1P is the most likely. In order to determine by independent means whether mechanism 1P or 2P is most appropriate, the method described by Mannervik was used [<xref ref-type="bibr" rid="B37">37</xref>], in which the quotient, <italic>F</italic><sub>exp </sub>(eq. 4) is compared with the <italic>F</italic>-statistic: <italic>F</italic>(<italic>p</italic><sub>k </sub>- <italic>p</italic><sub>j</sub>, <italic>n </italic>- <italic>p</italic><sub>k</sub>), where <italic>SS</italic><sub>j </sub>(= 1.254) is the residual sum of squares from the simpler model (mechanism 2P) with <italic>p</italic><sub>j </sub>(= 4) parameters, <italic>SS</italic><sub>k </sub>(= 0.268) is the residual sum of squares from the more complex model (mechanism 1P) with <italic>p</italic><sub>k </sub>(= 5) parameters and <italic>n </italic>(= 27) is the number of data points.</p><p><inline-formula><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M14" name="1471-2091-8-3-i13" overflow="scroll"><mml:semantics definitionURL="" encoding=""><mml:mrow><mml:msub><mml:mi>F</mml:mi><mml:mrow><mml:mi>exp</mml:mi><mml:mo>&#x02061;</mml:mo></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>S</mml:mi><mml:msub><mml:mi>S</mml:mi><mml:mtext>j</mml:mtext></mml:msub><mml:mo>&#x02212;</mml:mo><mml:mi>S</mml:mi><mml:msub><mml:mi>S</mml:mi><mml:mtext>k</mml:mtext></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mo stretchy="false">(</mml:mo><mml:mi>n</mml:mi><mml:mo>&#x02212;</mml:mo><mml:msub><mml:mi>p</mml:mi><mml:mtext>k</mml:mtext></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>p</mml:mi><mml:mtext>k</mml:mtext></mml:msub><mml:mo>&#x02212;</mml:mo><mml:msub><mml:mi>p</mml:mi><mml:mtext>j</mml:mtext></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mi>S</mml:mi><mml:msub><mml:mi>S</mml:mi><mml:mtext>k</mml:mtext></mml:msub></mml:mrow></mml:mfrac><mml:mtext>&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;</mml:mtext><mml:mrow><mml:mo>(</mml:mo><mml:mn>4</mml:mn><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:annotation encoding="MathType-MTEF"> MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacqWGgbGrdaWgaaWcbaGagiyzauMaeiiEaGNaeiiCaahabeaakiabg2da9maalaaabaGaeiikaGIaem4uamLaem4uam1aaSbaaSqaaiabbQgaQbqabaGccqGHsislcqWGtbWucqWGtbWudaWgaaWcbaGaee4AaSgabeaakiabcMcaPiabcIcaOiabd6gaUjabgkHiTiabdchaWnaaBaaaleaacqqGRbWAaeqaaOGaeiykaKcabaGaeiikaGIaemiCaa3aaSbaaSqaaiabbUgaRbqabaGccqGHsislcqWGWbaCdaWgaaWcbaGaeeOAaOgabeaakiabcMcaPiabdofatjabdofatnaaBaaaleaacqqGRbWAaeqaaaaakiaaxMaacaWLjaWaaeWaaeaaieqacqWF0aanaiaawIcacaGLPaaaaaa@550A@</mml:annotation></mml:semantics></mml:math></inline-formula></p><p>According to this method, the experimental quotient <italic>F</italic><sub>exp </sub>was 80.9, and the critical value for <italic>F</italic>(1,22) is 14.38 at a value of <italic>&#x003b1; </italic>= 0.001: therefore, the reaction follows mechanism 1P, with substrate inhibition by 5-aminosalicylic acid on both the free form of the enzyme and the enzyme&#x000b7;AcCoA complex. A schematic diagram illustrating this mechanism is given in Figure <xref ref-type="fig" rid="F2">2</xref>. Therefore, for concentrations of AcCoA at 800 &#x003bc;M and below, the rate equation for this reaction is as shown in equation 5.</p><fig position="float" id="F2"><label>Figure 2</label><caption><p><bold>The proposed kinetic mechanism of PANAT-catalysed <italic>N</italic>-acetylation of 5-aminosalicylic acid with AcCoA</bold>. The schematic diagram shows the catalytic cycle (boxed) and the non-productive binding of 5-AS (&#x025cf;) to the free form of the enzyme and to the enzyme&#x000b7;AcCoA complex. It is not known whether AcCoA is able to bind to the enzyme&#x000b7;5-AS complex.</p></caption><graphic xlink:href="1471-2091-8-3-2"/></fig><p><inline-formula><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M15" name="1471-2091-8-3-i14" overflow="scroll"><mml:semantics definitionURL="" encoding=""><mml:mrow><mml:mi>v</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>V</mml:mi><mml:mrow><mml:mi>max</mml:mi><mml:mo>&#x02061;</mml:mo></mml:mrow></mml:msub><mml:mi>a</mml:mi><mml:mi>A</mml:mi><mml:mi>b</mml:mi><mml:mi>B</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mtext>mB</mml:mtext></mml:mrow></mml:msub><mml:mi>a</mml:mi><mml:mi>A</mml:mi><mml:mo>+</mml:mo><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mtext>mA</mml:mtext></mml:mrow></mml:msub><mml:mi>b</mml:mi><mml:mi>B</mml:mi><mml:mo>+</mml:mo><mml:mi>a</mml:mi><mml:mi>A</mml:mi><mml:mi>b</mml:mi><mml:mi>B</mml:mi><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mtext>mA</mml:mtext></mml:mrow></mml:msub><mml:msup><mml:mi>b</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:msup><mml:mi>B</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mtext>si</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mtext>B</mml:mtext><mml:mo>&#x02192;</mml:mo><mml:mtext>E</mml:mtext><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msub></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mfrac><mml:mrow><mml:mi>a</mml:mi><mml:mi>A</mml:mi><mml:msup><mml:mi>b</mml:mi><mml:mn>2</mml:mn></mml:msup><mml:msup><mml:mi>B</mml:mi><mml:mn>2</mml:mn></mml:msup></mml:mrow><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mtext>si</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mtext>B</mml:mtext><mml:msubsup><mml:mo>&#x02192;</mml:mo><mml:mrow><mml:mtext>FP</mml:mtext></mml:mrow><mml:mrow><mml:mtext>EA</mml:mtext></mml:mrow></mml:msubsup><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msub></mml:mrow></mml:mfrac></mml:mrow></mml:mfrac><mml:mtext>&#x000a0;&#x000a0;&#x000a0;&#x000a0;&#x000a0;</mml:mtext><mml:mrow><mml:mo>(</mml:mo><mml:mn>5</mml:mn><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:annotation encoding="MathType-MTEF"> MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=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@785B@</mml:annotation></mml:semantics></mml:math></inline-formula></p><p>Thus, from the four rival kinetic mechanisms considered (Table <xref ref-type="table" rid="T2">2</xref>), an Ordered mechanism can be ruled out, based on the reduction of the denominator term <italic>&#x003b1; </italic>to zero in the calculation process, the correlations of the rival kinetic models and the statistical significance of the fits. Of the two remaining Ping Pong mechanisms, mechanism 2P is a poorer fit than mechanism 1P, as shown clearly by the observation of substrate inhibition by 5-aminosalicylic acid, the correlation of calculated and experimental self-consistency factors (<italic>den vs. den</italic><sub><italic>calc</italic></sub>) and the <italic>F</italic>-test comparisons. Therefore, the theoretical model which best fits the experimental data is a Ping Pong Bi Bi mechanism with substrate inhibition by the acceptor substrate 5-aminosalicylic acid on both the free form of the enzyme and the enzyme&#x000b7;AcCoA complex.</p></sec><sec><title>Determination of the half-life of the acetylated enzyme intermediate</title><p>In the absence of an acetyl acceptor, the proposed NAT reaction scheme is shown in Figure <xref ref-type="fig" rid="F3">3</xref>. The proposed scheme is based both on this study and on previously described work with a eukaryotic NAT [<xref ref-type="bibr" rid="B34">34</xref>]. Study of the first half of the Ping Pong Bi Bi reaction in this way allows for the determination of the half-life (<italic>t</italic><sub>1/2</sub>) of the acetyl-NAT intermediate, which is a measure of its stability. In the proposed reaction scheme, <italic>t</italic><sub>1/2 </sub>of the acetyl-NAT intermediate is dependent on both <italic>k</italic><sub>2 </sub>and <italic>k</italic><sub>3 </sub>(equations 6 and 7, Figure <xref ref-type="fig" rid="F3">3</xref>). If the rate of enzyme acetylation is very much faster than the rate of acetyl-enzyme hydrolysis (that is, if <italic>k</italic><sub>2 </sub>is very much larger than <italic>k</italic><sub>3</sub>), then <italic>t</italic><sub>1/2 </sub>of the acetyl-NAT intermediate may be approximated by the following equation: <inline-formula><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M16" name="1471-2091-8-3-i15" overflow="scroll"><mml:semantics definitionURL="" encoding=""><mml:mrow><mml:msub><mml:mi>t</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mo>/</mml:mo><mml:mn>2</mml:mn></mml:mrow></mml:msub><mml:mo>&#x02248;</mml:mo><mml:mfrac><mml:mrow><mml:mi>L</mml:mi><mml:mi>n</mml:mi><mml:mn>2</mml:mn></mml:mrow><mml:mrow><mml:msub><mml:mi>k</mml:mi><mml:mn>3</mml:mn></mml:msub></mml:mrow></mml:mfrac></mml:mrow><mml:annotation encoding="MathType-MTEF"> MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacqWG0baDdaWgaaWcbaGaeGymaeJaei4la8IaeGOmaidabeaakiabgIKi7oaalaaabaGaemitaWKaemOBa4MaeGOmaidabaGaem4AaS2aaSbaaSqaaiabiodaZaqabaaaaaaa@38D3@</mml:annotation></mml:semantics></mml:math></inline-formula> (equations 6&#x02013;8, Figure <xref ref-type="fig" rid="F3">3</xref>).</p><fig position="float" id="F3"><label>Figure 3</label><caption><p><bold>The steady-state formation and hydrolysis of the acetyl-enzyme intermediate</bold>. The acetyl donor is denoted AcX, where X is <italic>p</italic>-nitrophenol or CoA. AcNAT refers to the acetylated enzyme intermediate. For a derivation of equation 9, see [34].</p></caption><graphic xlink:href="1471-2091-8-3-3"/></fig><p>The rate of hydrolysis of the acetylated PANAT intermediate (AcNAT in Figure <xref ref-type="fig" rid="F3">3</xref>) has been determined under different experimental conditions where the acetyl donor is either <italic>p</italic>-nitrophenyl acetate or AcCoA, by measuring the rate of production of <italic>p</italic>-nitrophenol or CoA, and the results are shown in Figure <xref ref-type="fig" rid="F4">4</xref>. Equation 9 (Figure <xref ref-type="fig" rid="F3">3</xref>) was used to calculate the value of <italic>k</italic><sub>3 </sub>for the reaction under each set of experimental conditions, from which the half-life of the acetyl enzyme intermediate was calculated. The data are summarised in Table <xref ref-type="table" rid="T3">3</xref>.</p><fig position="float" id="F4"><label>Figure 4</label><caption><p><bold>PANAT-catalysed hydrolysis of acetyl donors</bold>. PANAT at 8 &#x003bc;M (&#x00394;), 4 &#x003bc;M (&#x025a1;) and a control using PBS buffer (&#x000d7;) were incubated with: <bold>A</bold>) <italic>p</italic>-nitrophenyl acetate (320 &#x003bc;M) or <bold>B</bold>) AcCoA (320 &#x003bc;M) at 25&#x000b0;C. The control experiments with PANAT (8 &#x003bc;M) and no acetyl donor (&#x025cb;) are also shown. Reactions were performed in quadruplicate at 25&#x000b0;C and pH 7.4 as described in Methods. The absorbance of <italic>p</italic>-nitrophenol or 5-thio-2-nitrobenzoic acid (produced by reaction with coenzyme A) is shown (<italic>y</italic>-axis) as a function of time (<italic>x</italic>-axis).</p></caption><graphic xlink:href="1471-2091-8-3-4"/></fig><table-wrap position="float" id="T3"><label>Table 3</label><caption><p>Determination of the half-life of the acetyl-enzyme intermediate.</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center">Acetyl Donor</td><td align="center" colspan="3">Rate of hydrolysis of acetyl donor (nM&#x000b7;s<sup>-1</sup>)<sup><italic>a</italic></sup></td><td align="center"><italic>k</italic><sub>3 </sub>(&#x000d7; 10<sup>-3</sup>&#x000b7;s<sup>-1</sup>)<sup><italic>b</italic></sup></td><td align="center"><italic>t</italic><sub>1/2 </sub>(s)<sup><italic>c</italic></sup></td></tr><tr><td></td><td colspan="3"><hr></hr></td><td></td><td></td></tr><tr><td></td><td align="center">No enzyme</td><td align="center">4 mM PANAT</td><td align="center">8 mM PANAT</td><td></td><td></td></tr></thead><tbody><tr><td align="center"><italic>p</italic>-Nitrophenyl acetate</td><td align="center">0.28 &#x000b1; 0.01</td><td align="center">12.2 &#x000b1; 0.5</td><td align="center">22.8 &#x000b1; 0.4</td><td align="center">2.83 &#x000b1; 0.08</td><td align="center">235 &#x000b1; 8</td></tr><tr><td align="center">AcCoA</td><td align="center">ND<sup><italic>d</italic></sup></td><td align="center">-</td><td align="center">21.2 &#x000b1; 3.9</td><td align="center">2.66 &#x000b1; 0.49</td><td align="center">270 &#x000b1; 49</td></tr></tbody></table><table-wrap-foot><p><sup><italic>a </italic></sup>The rates of hydrolysis were determined spectrophotometrically by measuring the rate of production of <italic>p</italic>-nitrophenol or CoA, as described in the text.</p><p><sup><italic>b </italic></sup><italic>k</italic><sub>3 </sub>values were determined according to equation 9 (Figure 3).</p><p><sup><italic>c </italic></sup><italic>t</italic><sub>1/2 </sub>values were calculated according to equation 8 (Figure 3).</p><p><sup><italic>d </italic></sup>ND, none detected.</p></table-wrap-foot></table-wrap><p>The rates of enzyme-catalysed hydrolysis of <italic>p</italic>-nitrophenyl acetate were 12.2 &#x000b1; 0.5 nM&#x000b7;s<sup>-1 </sup>for 4 &#x003bc;M PANAT and 22.8 &#x000b1; 0.4 nM&#x000b7;s<sup>-1 </sup>for 8 &#x003bc;M PANAT after correction for the non-enzymatic rate of reaction, which was 0.28 &#x000b1; 0.01 nM&#x000b7;s<sup>-1</sup>. These results give a <italic>k</italic><sub>3 </sub>value of 2.83 &#x000b1; 0.08 &#x000d7; 10<sup>-3 </sup>s<sup>-1</sup>, which corresponds to a value for <italic>t</italic><sub>1/2 </sub>of the acetyl-NAT intermediate of 235 &#x000b1; 8 s.</p><p>The rate of enzyme-catalysed hydrolysis of AcCoA was 21.2 &#x000b1; 3.9 nM&#x000b7;s<sup>-1 </sup>for 8 &#x003bc;M PANAT. Under the experimental conditions used, no hydrolysis of AcCoA was observed in the absence of enzyme. The calculated <italic>k</italic><sub>3 </sub>was 2.66 &#x000b1; 0.49 &#x000d7; 10<sup>-3 </sup>s<sup>-1</sup>, corresponding to a value for <italic>t</italic><sub>1/2 </sub>of acetyl-PANAT of 270 &#x000b1; 49 s. Thus, the half-life of the acetyl-PANAT intermediate is very similar when generated with <italic>p</italic>-nitrophenyl acetate or AcCoA as the acetyl donor.</p></sec><sec><title>Comparison of AcCoA and <italic>p</italic>-nitrophenyl acetate as acetyl donors</title><p>The rates of acetylation of the acceptors: 5-aminosalicylic acid, 2-aminofluorene, hydralazine, <italic>p</italic>-aminobenzoic acid, <italic>p</italic>-anisidine, isoniazid and aniline (500 &#x003bc;M) by PANAT with 400 &#x003bc;M <italic>p</italic>-nitrophenyl acetate as acetyl donor were determined by measuring the formation of <italic>p</italic>-nitrophenol spectrophotometrically at 405 nm. The specific activities were calculated, after correcting for the non-enzymatic and enzyme-catalysed hydrolysis of <italic>p</italic>-nitrophenyl acetate, and are shown in Table <xref ref-type="table" rid="T4">4</xref>. Solvent (DMSO) was found to have no effect on the rate of reaction at a final concentration of 5%. The experimentally determined specific activities for acetylation of acceptor substrates with the donor <italic>p</italic>-nitrophenyl acetate were compared with previously reported values where the acetyl donor was AcCoA (Table <xref ref-type="table" rid="T4">4</xref>). For the substrates used in this study, the rates of acetylation with <italic>p</italic>-nitrophenyl acetate were between 1.1-fold and 71-fold slower than the corresponding rates with AcCoA as the acetyl donor (Table <xref ref-type="table" rid="T4">4</xref>).</p><table-wrap position="float" id="T4"><label>Table 4</label><caption><p>Comparison of PANAT-catalysed <italic>N</italic>-acetylation with <italic>p</italic>-nitrophenyl acetate or AcCoA as acetyl donor<sup>a</sup></p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left"><bold>Substrate</bold></td><td align="center"><bold>Specific Activity &#x02013; PNPA (nmol&#x000b7;min<sup>-1</sup>&#x000b7;mg<sup>-1</sup>)<sup><italic>b</italic></sup></bold></td><td align="center"><bold>Specific Activity &#x02013; AcCoA (nmol&#x000b7;min<sup>-1</sup>&#x000b7;mg<sup>-1</sup>)<sup><italic>c</italic></sup></bold></td><td align="center"><bold>Fold Difference</bold></td></tr></thead><tbody><tr><td align="left">5-Aminosalicylic acid</td><td align="center">1040 &#x000b1; 30</td><td align="center">73300 &#x000b1; 3300</td><td align="center">70.5</td></tr><tr><td align="left">2-Aminofluorene</td><td align="center">1470 &#x000b1; 40</td><td align="center">44710 &#x000b1; 2720</td><td align="center">30.4</td></tr><tr><td align="left">Hydralazine</td><td align="center">2990 &#x000b1; 10</td><td align="center">29550 &#x000b1; 3110</td><td align="center">9.9</td></tr><tr><td align="left"><italic>p</italic>-Aminobenzoic acid</td><td align="center">841 &#x000b1; 17</td><td align="center">8200 &#x000b1; 78</td><td align="center">9.8</td></tr><tr><td align="left"><italic>p</italic>-Anisidine</td><td align="center">2220 &#x000b1; 40</td><td align="center">13500 &#x000b1; 0</td><td align="center">6.1</td></tr><tr><td align="left">Isoniazid</td><td align="center">602 &#x000b1; 3</td><td align="center">2324 &#x000b1; 0</td><td align="center">3.9</td></tr><tr><td align="left">Aniline</td><td align="center">567 &#x000b1; 7</td><td align="center">629 &#x000b1; 40</td><td align="center">1.1</td></tr></tbody></table><table-wrap-foot><p><sup><italic>a </italic></sup>The rate of production of <italic>p</italic>-nitrophenol was followed as described in Materials and Methods. Assay mixtures (100 &#x003bc;L) contained PANAT (50 ng), <italic>p</italic>-nitrophenyl acetate (400 &#x003bc;M) and acceptor substrate (500 &#x003bc;M) in PBS buffer with 5% (v/v) DMSO. Reactions were performed at 25&#x000b0;C, and specific activities are expressed as the mean &#x000b1; standard deviation from triplicate measurements.</p><p><sup><italic>b </italic></sup>PNPA, <italic>p</italic>-nitrophenyl acetate.</p><p><sup><italic>c </italic></sup>Specific activities with AcCoA as acetyl donor are the literature values determined under similar experimental conditions [7].</p></table-wrap-foot></table-wrap><p>When the acetyl donor <italic>p</italic>-nitrophenyl acetate is used, the product of the initial enzyme acetylation step is <italic>p</italic>-nitrophenol. The rate of the PANAT-catalysed acetylation of 5-aminosalicylic acid with either of the acetyl donors <italic>p</italic>-nitrophenyl acetate or AcCoA was not changed in the presence of <italic>p</italic>-nitrophenol at concentrations up to 100 &#x003bc;M. Therefore, it is unlikely that the slower rate of reaction with <italic>p</italic>-nitrophenyl acetate compared to AcCoA observed in the present study is due to product inhibition by the <italic>p</italic>-nitrophenol produced in the first half of the Ping Pong Bi Bi reaction. When AcCoA is used as the acetyl donor, CoA is the product of the initial enzyme-acetylation step. Andres and colleagues noted marked product inhibition by CoA [<xref ref-type="bibr" rid="B24">24</xref>], which may explain the reported results with the STNAT enzyme and NAT from pigeon livers, where the rates of acetylation of acceptor substrates were faster when <italic>p</italic>-nitrophenyl acetate was used instead of AcCoA as the acetyl donor [<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B38">38</xref>]. Product inhibition by CoA does not explain the results obtained in this study with the PANAT enzyme; however, it is possible that the 71-fold slower acetylation of 5-aminosalicylic acid with <italic>p</italic>-nitrophenyl acetate as the acetyl donor instead of AcCoA may be due to the substrate inhibition exhibited by 5-aminosalicylic acid. As shown in this study, 5-aminosalicylic acid binds to the free form of the enzyme and the enzyme&#x000b7;AcCoA complex, both of which are inhibitory pathways in the proposed reaction mechanism (Figure <xref ref-type="fig" rid="F2">2</xref>). As 5-aminosalicylic acid is structurally more similar to <italic>p</italic>-nitrophenyl acetate than to AcCoA, it is possible that the effects of the observed substrate inhibition mechanisms would be greater when <italic>p</italic>-nitrophenyl acetate is used as the acetyl donor instead of AcCoA.</p></sec></sec><sec><title>Discussion</title><p>This study shows that NAT from <italic>P. aeruginosa </italic>follows the Ping Pong Bi Bi kinetic mechanism [<xref ref-type="bibr" rid="B27">27</xref>], in which the enzyme binds AcCoA, and the acetyl group is transferred to the enzyme. CoA is released, leaving a stable acetyl-enzyme intermediate, which then binds the second substrate. The acetyl group is transferred, regenerating the native enzyme and <italic>N</italic>-acetylated substrate. While various previous studies have shown that eukaryotic NAT enzymes follow Ping Pong Bi Bi kinetics [<xref ref-type="bibr" rid="B23">23</xref>,<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B26">26</xref>], this study constitutes the first such analysis reported for a prokaryotic NAT. A summary of all kinetic parameters determined by the normalised plot method in this study is presented in Table <xref ref-type="table" rid="T5">5</xref>. The normalised plot method allows for a full kinetic description of the system to be obtained with fewer required data points than conventional methods, and therefore reduced usage of expensive reagents, such as acetyl coenzyme A. The method also overcomes the experimental problems associated with the determination of apparent kinetic parameters, such as substrate inhibition. Structural studies and NMR experiments have previously demonstrated an interaction of the acetyl acceptor substrate, isoniazid, with NATs from <italic>M. smegmatis </italic>(MSNAT, [<xref ref-type="bibr" rid="B39">39</xref>]) and <italic>S. typhimurium </italic>(STNAT, [<xref ref-type="bibr" rid="B40">40</xref>]) in the absence of AcCoA. Sandy and colleagues suggested that the binding of isoniazid to MSNAT may constitute either a substrate inhibition complex or a pre-Ping Pong initiation step in the reaction mechanism [<xref ref-type="bibr" rid="B39">39</xref>]. The present study shows that the suggested pre-Ping Pong step is unlikely, and that binding of the acetyl acceptor substrate to the free form of the enzyme is an inhibitory pathway. We have shown that 5-aminosalicylic acid exhibits substrate inhibition by binding both to the free enzyme and to the enzyme&#x000b7;AcCoA complex. A schematic diagram of the proposed mechanism is presented in Figure <xref ref-type="fig" rid="F2">2</xref>. In the search for possible endogenous substrates and novel inhibitors of NAT enzymes by structure-based rational drug design, the enzyme&#x000b7;AcCoA complex and the acetyl-enzyme intermediate need to be studied as well as the native enzyme. A non-hydrolysable model of the acetyl-enzyme intermediate of MSNAT, in which the active-site cysteine residue is mutated to a glutamine, has been obtained by X-ray crystallography to a resolution of 1.45 &#x000c5; [<xref ref-type="bibr" rid="B10">10</xref>]. Computational models of acetyl-enzyme&#x000b7;CoA and acetyl-enzyme&#x000b7;ligand complexes can therefore be generated by co-crystallisation studies with corresponding cysteine/glutamine mutants of other bacterial NATs.</p><table-wrap position="float" id="T5"><label>Table 5</label><caption><p>A summary of all kinetic constants determined for the PANAT-catalysed acetylation of 5-aminosalicylic acid</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center">Constant<sup><italic>a</italic></sup></td><td align="center">Value</td></tr></thead><tbody><tr><td align="center"><italic>K</italic><sub>mA</sub></td><td align="center">1.02 &#x000b1; 0.29 mM</td></tr><tr><td align="center"><italic>K</italic><sub>mB</sub></td><td align="center">0.219 &#x000b1; 0.073 mM</td></tr><tr><td align="center"><italic>K</italic><sub>si(B&#x02192;E)</sub></td><td align="center">1.93 &#x000b1; 0.28 mM</td></tr><tr><td align="center"><inline-formula><mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M17" name="1471-2091-8-3-i11" overflow="scroll"><mml:semantics definitionURL="" encoding=""><mml:mrow><mml:msub><mml:mi>K</mml:mi><mml:mrow><mml:mtext>si</mml:mtext><mml:mo stretchy="false">(</mml:mo><mml:mtext>B</mml:mtext><mml:msubsup><mml:mo>&#x02192;</mml:mo><mml:mrow><mml:mtext>FP</mml:mtext></mml:mrow><mml:mrow><mml:mtext>EA</mml:mtext></mml:mrow></mml:msubsup><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:msub></mml:mrow><mml:annotation encoding="MathType-MTEF"> MathType@MTEF@5@5@+=feaafiart1ev1aaatCvAUfKttLearuWrP9MDH5MBPbIqV92AaeXatLxBI9gBaebbnrfifHhDYfgasaacH8akY=wiFfYdH8Gipec8Eeeu0xXdbba9frFj0=OqFfea0dXdd9vqai=hGuQ8kuc9pgc9s8qqaq=dirpe0xb9q8qiLsFr0=vr0=vr0dc8meaabaqaciaacaGaaeqabaqabeGadaaakeaacqWGlbWsdaWgaaWcbaGaee4CamNaeeyAaKMaeiikaGIaeeOqaiKaeyOKH46aa0baaWqaaiabbAeagjabbcfaqbqaaiabbweafjabbgeabbaaliabcMcaPaqabaaaaa@39F4@</mml:annotation></mml:semantics></mml:math></inline-formula></td><td align="center">1.03 &#x000b1; 0.34 mM</td></tr><tr><td align="center"><italic>V</italic><sub>max</sub></td><td align="center">1.75 &#x000b1; 0.07 &#x003bc;M&#x000b7;s<sup>-1</sup></td></tr><tr><td align="center"><italic>k</italic><sub>cat</sub></td><td align="center">434 &#x000b1; 17 s<sup>-1</sup></td></tr><tr><td align="center"><italic>k</italic><sub>cat</sub>/<italic>K</italic><sub>mA</sub></td><td align="center">468 &#x000b1; 150 mM<sup>-1</sup>&#x000b7;s<sup>-1</sup></td></tr><tr><td align="center"><italic>k</italic><sub>cat</sub>/<italic>K</italic><sub>mB</sub></td><td align="center">2259 &#x000b1; 830 mM<sup>-1</sup>&#x000b7;s<sup>-1</sup></td></tr></tbody></table><table-wrap-foot><p><sup><italic>a </italic></sup>Abbreviations: A, AcCoA; B, 5-aminosalicylic acid; E, PANAT; F, acetyl-PANAT.</p></table-wrap-foot></table-wrap><p>The first steps of any Ping Pong Bi Bi mechanism are the binding and reaction of the first substrate with the enzyme, resulting in the formation of a stable, non-native enzyme intermediate [<xref ref-type="bibr" rid="B27">27</xref>]. The isolation of a stable enzyme intermediate may be taken as positive evidence for a Ping Pong mechanism over an Ordered mechanism, in which all substrates bind to the enzyme prior to the release of the first product [<xref ref-type="bibr" rid="B27">27</xref>]. Figure <xref ref-type="fig" rid="F3">3</xref> shows the generic reaction of NAT with an acetyl donor in the absence of acceptor substrate. The acetylation of hamster NAT2 with <italic>p</italic>-nitrophenyl acetate has been shown to be rapid, by stopped-flow techniques [<xref ref-type="bibr" rid="B34">34</xref>]. For hamster NAT2, the rate of hydrolysis of the acetyl-enzyme intermediate was found to be rate limiting, with a <italic>k</italic><sub>3 </sub>of 7.85 &#x000b1; 0.65 &#x000d7; 10<sup>-3 </sup>s<sup>-1 </sup>compared with an estimated <italic>k</italic><sub>2 </sub>of 1301 &#x000b1; 720 s<sup>-1 </sup>and <italic>k</italic><sub>obs </sub>of 44.8 s<sup>-1 </sup>[<xref ref-type="bibr" rid="B34">34</xref>], which satisfies the assumptions that <italic>k</italic><sub>2 </sub>&#x0003e;&#x0003e; <italic>k</italic><sub>3 </sub>and <italic>k</italic><sub>obs </sub>&#x0003e;&#x0003e; <italic>k</italic><sub>3 </sub>(Figure <xref ref-type="fig" rid="F3">3</xref>). We have shown that PANAT catalyses the hydrolysis of both <italic>p</italic>-nitrophenyl acetate and AcCoA in the absence of acetyl acceptor substrate (Figure <xref ref-type="fig" rid="F4">4</xref>). Apart from two <italic>C</italic>-terminal truncation mutants of STNAT [<xref ref-type="bibr" rid="B38">38</xref>], no other bacterial NAT has been reported to exhibit this arylamine-independent activity. The lack of observed arylamine-independent acetyl-donor hydrolysis is most likely due to the significantly lower specific activity of the enzyme in the absence of an acetyl acceptor compared with when an acetyl acceptor is present [<xref ref-type="bibr" rid="B7">7</xref>], meaning that a high concentration of enzyme is required in order to measure the reaction rate of AcCoA hydrolysis in the absence of an acetyl acceptor. In the present study, the specific activity of PANAT-catalysed acetyl donor hydrolysis was 15,000-fold greater in the presence of the acceptor substrate 5-aminosalicylic acid compared with the acceptor-independent specific activity.</p><p>It has not been possible to detect an acetylated-STNAT enzyme intermediate by <sup>1</sup>H and <sup>13</sup>C NMR experiments [<xref ref-type="bibr" rid="B41">41</xref>], and it was concluded that, if an acetyl-STNAT intermediate were formed, its half-life would be considerably shorter than the timescale of the NMR experiments (~30 min). The half-life of acetyl-PANAT intermediate as determined in the present study (235 &#x000b1; 8 s, Figure <xref ref-type="fig" rid="F4">4</xref>), is considerably shorter than the timescale of the NMR experiment. Jencks and colleagues measured the half-life of the acetylated NAT from pigeon liver as less than 1 min [<xref ref-type="bibr" rid="B32">32</xref>]. More recently, Wagner, Hanna and co-workers measured the half-life of the acetylated NAT2 enzyme from Syrian hamsters at 88.3 &#x000b1; 8.3 s [<xref ref-type="bibr" rid="B34">34</xref>]. While the half-lives of the prokaryotic and eukaryotic enzymes are of a similar order of magnitude, the results obtained in this study suggest that the acetyl-PANAT intermediate may be more stable with respect to hydrolysis than both the acetyl-NAT intermediates from Syrian hamster and pigeon liver [<xref ref-type="bibr" rid="B32">32</xref>,<xref ref-type="bibr" rid="B34">34</xref>].</p><p>The apparent and true Michaelis constants for AcCoA from studies with pigeon liver NAT [<xref ref-type="bibr" rid="B29">29</xref>], hamster NAT2 [<xref ref-type="bibr" rid="B35">35</xref>], rabbit liver NAT [<xref ref-type="bibr" rid="B26">26</xref>], the full-length STNAT protein [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B38">38</xref>] and <italic>C</italic>-terminal truncation mutants of STNAT [<xref ref-type="bibr" rid="B38">38</xref>] are shown in Table <xref ref-type="table" rid="T6">6</xref>. The true <italic>K</italic><sub>m </sub>values for AcCoA appear to lie in the 1&#x02013;6 mM range for the different enzymes, whilst the apparent Michaelis constants vary by approximately three orders of magnitude, depending on the enzyme and acetyl acceptor substrate used.</p><table-wrap position="float" id="T6"><label>Table 6</label><caption><p>Summary of Michaelis constants for AcCoA from different NATs.</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center">Enzyme</td><td align="center">True or Apparent <italic>K</italic><sub>m</sub></td><td align="center">Acetyl Acceptor<sup><italic>d</italic></sup></td><td align="center"><italic>K</italic><sub>m</sub>(mM)</td><td align="center">Reference</td></tr></thead><tbody><tr><td align="center">PANAT</td><td align="center">Apparent</td><td align="center"><italic>p</italic>-anisidine (0.2 &#x003bc;M)</td><td align="center">0.136</td><td align="center">[7]</td></tr><tr><td align="center">PANAT</td><td align="center">Apparent</td><td align="center"><italic>p</italic>-anisidine (2 mM)</td><td align="center">0.466 &#x000b1; 0.077</td><td align="center">[see Additional file <xref ref-type="supplementary-material" rid="S2">2</xref>]</td></tr><tr><td align="center">PANAT</td><td align="center">True</td><td align="center">5-AS</td><td align="center">1.02 &#x000b1; 0.29</td><td align="center">Table 5</td></tr><tr><td align="center">STNAT<sup>a</sup></td><td align="center">Apparent</td><td align="center"><italic>N</italic>-OH-Glu-P-1</td><td align="center">0.010</td><td align="center">[1]</td></tr><tr><td align="center">STNAT<sup>a</sup></td><td align="center">Apparent</td><td align="center">INH</td><td align="center">&#x0003c; 0.020</td><td align="center">[38]</td></tr><tr><td align="center">STNAT - 11<sup><italic>b</italic></sup></td><td align="center">Apparent</td><td align="center">INH</td><td align="center">0.393 &#x000b1; 0.003</td><td align="center">[38]</td></tr><tr><td align="center">STNAT - 85<sup><italic>c</italic></sup></td><td align="center">Apparent</td><td align="center">INH</td><td align="center">0.764 &#x000b1; 0.004</td><td align="center">[38]</td></tr><tr><td align="center">Pigeon liver NAT</td><td align="center">Apparent</td><td align="center"><italic>p</italic>-nitroaniline</td><td align="center">0.007</td><td align="center">[29]</td></tr><tr><td align="center">Hamster NAT2</td><td align="center">True</td><td align="center"><italic>p</italic>-nitroaniline, pABA, pABA-Glu</td><td align="center">5.94</td><td align="center">[35]</td></tr><tr><td align="center">Rabbit liver NAT</td><td align="center">Apparent</td><td align="center">INH</td><td align="center">1.5</td><td align="center">[26]</td></tr></tbody></table><table-wrap-foot><p>Selected Michaelis constants from the literature have been compiled along with those determined in this study for the purified PANAT enzyme.</p><p><sup><italic>a </italic></sup>STNAT, NAT from <italic>Salmonella typhimurium</italic>.</p><p><sup><italic>b </italic></sup>STNAT truncation mutant, missing 11 amino acids from the <italic>C</italic>-terminus.</p><p><sup><italic>c </italic></sup>STNAT truncation mutant, missing the entire <italic>C</italic>-terminal domain (85 amino acids).</p><p><sup><italic>d </italic></sup>Abbreviations: 5-AS, 5-aminosalicylic acid; <italic>N</italic>-OH-Glu-P-1, 2-hydroxyamino-6-methyldipyrido- [1,2-<italic>a</italic>:3',2'-<italic>d</italic>]-imidazole; INH, isoniazid; pABA, <italic>p</italic>-aminobenzoic acid; pABA-Glu, <italic>p</italic>-aminobenzoyl-L-glutamate.</p></table-wrap-foot></table-wrap><p>The apparent kinetic parameters for AcCoA have been determined previously with recombinant PANAT enzyme and <italic>p</italic>-anisidine as the acetyl acceptor at a concentration of 200 &#x003bc;M [<xref ref-type="bibr" rid="B7">7</xref>]. In this study, we have used a higher concentration of <italic>p</italic>-anisidine (2 mM) to determine the apparent kinetic parameters for AcCoA under conditions that closer approach pseudo-first order kinetics [see Additional file <xref ref-type="supplementary-material" rid="S2">2</xref>]. The following values were obtained from a Hanes plot [see Additional file <xref ref-type="supplementary-material" rid="S2">2</xref>]: the apparent Michaelis constant for AcCoA (<italic>K</italic><sub>m,app</sub>) of 466 &#x000b1; 77 &#x003bc;M, apparent limiting rate (<italic>V</italic><sub>max,app</sub>) of 362 &#x000b1; 54 nM&#x000b7;s<sup>-1</sup>, apparent turnover number (<italic>k</italic><sub>cat,app</sub>) of 17.5 &#x000b1; 2.6 s<sup>-1 </sup>and apparent specificity constant (<italic>k</italic><sub>cat,app</sub>/<italic>K</italic><sub>m,app</sub>) of 37.6 &#x000b1; 5.4 mM<sup>-1</sup>&#x000b7;s<sup>-1</sup>. The previous studies with a lower concentration of <italic>p</italic>-anisidine as the acceptor substrate (200 &#x003bc;M) gave values for <italic>K</italic><sub>m,app </sub>of 136 &#x003bc;M and <italic>V</italic><sub>max,app </sub>of 153 nM&#x000b7;s<sup>-1 </sup>[<xref ref-type="bibr" rid="B7">7</xref>]. At the relatively high acceptor substrate concentration of 2 mM, the apparent Michaelis constant was less than 50% of its true value (1.02 &#x000b1; 0.29 mM), as determined with the normalised plot method in this study. Considering the very hydrophobic nature of many of the known acetyl acceptor substrates of NATs [<xref ref-type="bibr" rid="B42">42</xref>], it is not surprising that, in practice, the substrate concentrations required to reach pseudo-first order kinetics are often at or beyond the limit of solubility.</p><p>A summary of reported <italic>K</italic><sub>m </sub>values for AcCoA with various NAT enzymes is given in Table <xref ref-type="table" rid="T6">6</xref>. The very low apparent <italic>K</italic><sub>m </sub>values for AcCoA with STNAT and NAT from pigeon livers may not be due solely to the experimental conditions used. For the reaction with hamster NAT2, it has been suggested that the deacetylation step with <italic>p</italic>-nitroaniline is rate limiting [<xref ref-type="bibr" rid="B35">35</xref>], which results in a decrease in the measured apparent <italic>K</italic><sub>m </sub>for AcCoA compared with the true value. In the same study, the deacetylation step with <italic>p</italic>-aminobenzoic acid or <italic>p</italic>-aminobenzoyl-L-glutamate as the acetyl acceptor was found to be partially rate-limiting, thus the apparent Michaelis constants for AcCoA when using these substrates are also lower than the true value [<xref ref-type="bibr" rid="B35">35</xref>]. Therefore, it is likely that the comparatively low apparent <italic>K</italic><sub>m </sub>values measured for STNAT [<xref ref-type="bibr" rid="B38">38</xref>] and pigeon NAT [<xref ref-type="bibr" rid="B23">23</xref>] reflect a rate-limiting deacetylation step in the presence of the acetyl acceptor substrates isoniazid, <italic>N</italic>-OH-Glu-P-1 and <italic>p</italic>-nitroaniline (Table <xref ref-type="table" rid="T6">6</xref>).</p><p>The Michaelis constant for AcCoA with hamster NAT2 (5.94 mM) is nearly 6 times higher than the <italic>K</italic><sub>m </sub>for AcCoA (1.02 &#x000b1; 0.29 mM) determined with PANAT in the present study [<xref ref-type="bibr" rid="B35">35</xref>]. This indicates that AcCoA has a greater affinity for PANAT than for hamster NAT2. It is therefore possible that the longer half-life of the acetyl-PANAT intermediate compared to that of acetyl-NAT2 from hamsters may be due to the greater stability of the PANAT&#x000b7;AcCoA (or the acetyl-PANAT&#x000b7;CoA) complex.</p><p>The <italic>K</italic><sub>m </sub>value for AcCoA with PANAT is significantly larger than the <italic>K</italic><sub>m,app </sub>value for AcCoA with the STNAT protein [<xref ref-type="bibr" rid="B38">38</xref>]. However, the two <italic>C</italic>-terminal truncation mutants of STNAT, reported by Mushtaq and colleagues [<xref ref-type="bibr" rid="B38">38</xref>], have apparent Michaelis constants which are very similar to the <italic>K</italic><sub>m </sub>for AcCoA with PANAT. The STNAT sequence has eight more residues at the <italic>C</italic>-terminus than the PANAT sequence, and this <italic>C</italic>-terminal section of the STNAT is responsible for the observed differences in the truncation mutants compared with the full-length protein [<xref ref-type="bibr" rid="B38">38</xref>]. The comparatively shorter length of the <italic>C</italic>-terminus of PANAT may therefore be responsible for the higher apparent <italic>K</italic><sub>m </sub>for AcCoA. The X-ray crystal structures of the two proteins are available, and a comparison of the <italic>C</italic>-terminal residues of these proteins indicates that a cleft which leads to the active site is blocked by the <italic>C</italic>-terminus of STNAT relative to that of PANAT (Figure <xref ref-type="fig" rid="F5">5</xref>). The terminal residue (Leu<sup>276</sup>) in the PANAT structure is 25.8 &#x000c5; from the active site cysteine, compared to 17.6 &#x000c5; between Phe<sup>273 </sup>and the active site Cys in STNAT.</p><fig position="float" id="F5"><label>Figure 5</label><caption><p><bold>A comparison of the <italic>C</italic>-terminal residues of STNAT and PANAT</bold>. The active-site triad residues of PANAT (Cys-His-Asp) and the <italic>C</italic>-terminal residues of PANAT (purple) and STNAT (black) are shown in ball and stick representation. The distances between the active site Cys sulfur atom and residues Leu<sup>276 </sup>and Phe<sup>273 </sup>from PANAT and STNAT respectively are 25.8 &#x000c5; and 17.6 &#x000c5; respectively, and were determined by using SwissPDB Viewer [46]. The figure was produced with Aesop (M. E. M. Noble, unpublished results).</p></caption><graphic xlink:href="1471-2091-8-3-5"/></fig></sec><sec><title>Conclusion</title><p>We have shown that NAT from <italic>Pseudomonas aeruginosa </italic>follows a Ping Pong Bi Bi kinetic mechanism with substrate inhibition, by using a normalised plot method. This is the first reported study of the kinetic mechanism of a bacterial NAT. These studies provide a basis for the understanding of the molecular interactions of small-molecule ligands with NAT enzymes, and establish a reliable, reproducible and efficient method for the determination of kinetic parameters.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Protein preparation</title><p>Recombinant PANAT was prepared and purified as previously described [<xref ref-type="bibr" rid="B7">7</xref>]. Repeated concentration and dilution was used to exchange the buffer of protein solutions from the Tris.HCl buffers used during purification to phosphate-buffered saline (PBS, 0.137 mM NaCl, 2.7 mM KCl, 4.3 mM Na<sub>2</sub>HPO<sub>4</sub>, 1.4 mM KH<sub>2</sub>PO<sub>4</sub>, pH 7.4). Protein solutions were concentrated by using Amicon centrifugal filter devices (10,000 MW Cut-off, Millipore). The concentrations of solutions containing purified PANAT were determined spectrophotometrically with a Hitachi U2001 spectrophotometer by using the molar extinction coefficient (&#x003b5;<sub>280</sub>) of 33120 M<sup>-1</sup>.cm<sup>-1 </sup>(calculated with ProtParam [<xref ref-type="bibr" rid="B43">43</xref>,<xref ref-type="bibr" rid="B44">44</xref>]).</p></sec><sec><title>Normalised plot analysis</title><p>The method of Bravo and colleagues [<xref ref-type="bibr" rid="B36">36</xref>] was used to determine the true kinetic parameters of the PANAT-catalysed acetylation of 5-aminosalicylic acid with AcCoA as the acetyl donor. A flowchart describing the approach is given as supplemental material [see Additional file <xref ref-type="supplementary-material" rid="S1">1</xref>]. The kinetic parameters are defined as follows: <italic>K</italic><sub>mA </sub>and <italic>K</italic><sub>mB</sub>, true Michaelis constants for substrates A (AcCoA) and B (5-aminosalicylic acid) respectively; <italic>K</italic><sub>iA</sub>, dissociation constant of the EA complex (Ordered mechanism only); <italic>K</italic><sub>si(B&#x02192;E)</sub>, dissociation constant of the EB complex to free enzyme (E) and free substrate (B). The subscript 'si' refers to substrate inhibition by the substrate on the enzyme form indicated in brackets. The nomenclature proposed by Cleland [<xref ref-type="bibr" rid="B27">27</xref>] has been used throughout for enzyme forms and complexes; thus, E is the free form of PANAT and F is the acetyl-NAT intermediate. Non-linear regression analyses were performed by using KyPlot v2.0 beta 13 [<xref ref-type="bibr" rid="B45">45</xref>] with the least-squares method.</p></sec><sec><title>Determination of acetyl-enzyme half-life</title><p>Assays measuring the hydrolysis of the acetyl donors <italic>p</italic>-nitrophenyl acetate and acetyl coenzyme A (AcCoA) were performed in the absence of an acetyl acceptor substrate. The assay solutions (100 &#x003bc;L) contained PANAT (8, 4 or 0 &#x003bc;M; 26.7, 13.3 or 0 &#x003bc;g) and either AcCoA or p-nitrophenyl acetate (320 &#x003bc;M) in PBS (pH 7.4) containing 5% (v/v) dimethylsulfoxide (DMSO). The reactions were started by the addition of acetyl donor (5 &#x003bc;L) in DMSO or PBS. The production of p-nitrophenol was followed spectrophotometrically at 405 nm in a continuous assay with a Hitachi U2001 spectrophotometer or a Tecan Sunrise 96-well plate reader; the molar extinction coefficient of p-nitrophenol at this wavelength (&#x003b5;<sub>405</sub>) is 13400 M-1.cm-1, and data were collected at 30 s intervals. The rate of formation of CoA was determined spectrophotometrically (Tecan Sunrise 96-well plate reader) by following the reaction of CoA with the colorimetric agent 5,5'-dithio-bis(2-nitrobenzoic acid) (DTNB, 5 mM) in stop buffer (25 &#x003bc;L, 100 mM Tris.HCl, 6.4 M guanidine.HCl, pH 7.3) in a non-continuous assay as previously described [<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B12">12</xref>]. All assays were performed at 25&#x000b0;C, and rates are relative to the non-enzymatic hydrolysis of AcCoA, expressed as the mean &#x000b1; standard deviation of quadruplicate measurements.</p></sec><sec><title>Determination of NAT-catalysed <italic>N</italic>-acetylation activity</title><p>Assays measuring the <italic>N</italic>-acetylation activity of PANAT were performed with the acetyl donors <italic>p</italic>-nitrophenyl acetate and AcCoA, and the acetyl acceptors 5-aminosalicylic acid, 2-aminofluorene, hydralazine, <italic>p</italic>-aminobenzoic acid, <italic>p</italic>-anisidine, isoniazid and aniline. Assay solutions (100 &#x003bc;L) contained PANAT (3.4 &#x02013; 20.7 nM, 11 &#x02013; 69 ng), acetyl donor (0.05 &#x02013; 6.00 mM) and acetyl acceptor (0.05 &#x02013; 3.00 mM) in 20 mM Tris.HCl buffer (pH 8.0) or PBS. Reactions were started by the addition of acetyl donor and the rates of production of <italic>p</italic>-nitrophenol or CoA were determined as described above. All assays were performed at 25&#x000b0;C, and controls were included in which no enzyme or no substrate was added. All rates are relative to the non-enzymatic hydrolysis of acetyl donor, and are expressed as the mean &#x000b1; standard deviation of triplicate or quadruplicate measurements.</p></sec></sec><sec><title>Authors' contributions</title><p>IMW carried out the enzyme assays and kinetic analyses. ES conceived of the study. Both authors participated in the experimental design, the interpretation of the data and the drafting of the manuscript. Both authors confirm that they have read and approved the final manuscript.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="S1"><caption><title>Additional file 1</title><p>Flow diagram describing the normalised plot method. A flow diagram outlining how data from the normalised plot method are analysed.</p></caption><media xlink:href="1471-2091-8-3-S1.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S2"><caption><title>Additional file 2</title><p>Hanes plot for AcCoA as a substrate of PANAT with the acetyl acceptor <italic>p</italic>-anisidine. This Hanes plot shows the determination of the apparent Michaelis constant for acetyl coenzyme A with the PANAT enzyme in the presence of the acceptor substrate <italic>p</italic>-anisidine.</p></caption><media xlink:href="1471-2091-8-3-S2.doc" mimetype="application" mime-subtype="msword"><caption><p>Click here for file</p></caption></media></supplementary-material></sec></body><back><ack><sec><title>Acknowledgements</title><p>This work was supported by an MRC graduate studentship (IMW) and a Wellcome Trust Programme Grant (ES, WT 067887). The authors thank Patrick E. Hanna (University of Minnesota), Carston R. Wagner (University of Minnesota), Akane Kawamura (University of Oxford), D. James Sandy (University of Oxford) and Peter Mackenzie (Flinders University, Adelaide) for helpful advice and discussion.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>M</given-names></name><name><surname>Sofuni</surname><given-names>T</given-names></name><name><surname>Nohmi</surname><given-names>T</given-names></name></person-group><article-title>Involvement of Cys69 residue in the catalytic mechanism of N-hydroxyarylamine O-acetyltransferase of Salmonella typhimurium. Sequence similarity at the amino acid level suggests a common catalytic mechanism of acetyltransferase for S. typhimurium and higher organisms.</article-title><source>J Biol Chem</source><year>1992</year><volume>267</volume><fpage>8429</fpage><lpage>8436</lpage><pub-id pub-id-type="pmid">1569093</pub-id></citation></ref><ref id="B2"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Floss</surname><given-names>HG</given-names></name><name><surname>Yu</surname><given-names>TW</given-names></name></person-group><article-title>Lessons from the rifamycin biosynthetic gene cluster</article-title><source>Curr Opin Chem Biol</source><year>1999</year><volume>3</volume><fpage>592</fpage><lpage>597</lpage><pub-id pub-id-type="pmid">10508670</pub-id><pub-id pub-id-type="doi">10.1016/S1367-5931(99)00014-9</pub-id></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bhakta</surname><given-names>S</given-names></name><name><surname>Besra</surname><given-names>GS</given-names></name><name><surname>Upton</surname><given-names>AM</given-names></name><name><surname>Parish</surname><given-names>T</given-names></name><name><surname>Sholto-Douglas-Vernon</surname><given-names>C</given-names></name><name><surname>Gibson</surname><given-names>KJC</given-names></name><name><surname>Knutton</surname><given-names>S</given-names></name><name><surname>Gordon</surname><given-names>S</given-names></name><name><surname>daSilva</surname><given-names>RP</given-names></name><name><surname>Anderton</surname><given-names>MC</given-names></name><name><surname>Sim</surname><given-names>E</given-names></name></person-group><article-title>Arylamine N-acetyltransferase is required for synthesis of mycolic acids and complex lipids in Mycobacterium bovis BCG and represents a novel drug target</article-title><source>J Exp Med</source><year>2004</year><volume>199</volume><fpage>1191</fpage><lpage>1199</lpage><pub-id pub-id-type="pmid">15117974</pub-id><pub-id pub-id-type="doi">10.1084/jem.20031956</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sinclair</surname><given-names>JC</given-names></name><name><surname>Delgoda</surname><given-names>R</given-names></name><name><surname>Noble</surname><given-names>ME</given-names></name><name><surname>Jarmin</surname><given-names>S</given-names></name><name><surname>Goh</surname><given-names>NK</given-names></name><name><surname>Sim</surname><given-names>E</given-names></name></person-group><article-title>Purification, characterization, and crystallization of an N-hydroxyarylamine O-acetyltransferase from Salmonella typhimurium</article-title><source>Protein Expr Purif</source><year>1998</year><volume>12</volume><fpage>371</fpage><lpage>380</lpage><pub-id pub-id-type="pmid">9535705</pub-id><pub-id pub-id-type="doi">10.1006/prep.1997.0856</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Payton</surname><given-names>M</given-names></name><name><surname>Auty</surname><given-names>R</given-names></name><name><surname>Delgoda</surname><given-names>R</given-names></name><name><surname>Everett</surname><given-names>M</given-names></name><name><surname>Sim</surname><given-names>E</given-names></name></person-group><article-title>Cloning and characterization of arylamine N-acetyltransferase genes from Mycobacterium smegmatis and Mycobacterium tuberculosis: increased expression results in isoniazid resistance</article-title><source>J Bacteriol</source><year>1999</year><volume>181</volume><fpage>1343</fpage><lpage>1347</lpage><pub-id pub-id-type="pmid">9973365</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Holton</surname><given-names>SJ</given-names></name><name><surname>Dairou</surname><given-names>J</given-names></name><name><surname>Sandy</surname><given-names>J</given-names></name><name><surname>Rodrigues-Lima</surname><given-names>F</given-names></name><name><surname>Dupret</surname><given-names>JM</given-names></name><name><surname>Noble</surname><given-names>M</given-names></name><name><surname>Sim</surname><given-names>E</given-names></name></person-group><article-title>Structure of Mesorhizobium loti arylamine N-acetyltransferase 1</article-title><source>Acta Crystallograph Sect F Struct Biol Cryst Commun</source><year>2005</year><volume>61</volume><fpage>14</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">16508079</pub-id><pub-id pub-id-type="doi">10.1107/S1744309104030659</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Westwood</surname><given-names>IM</given-names></name><name><surname>Holton</surname><given-names>SJ</given-names></name><name><surname>Rodrigues-Lima</surname><given-names>F</given-names></name><name><surname>Dupret</surname><given-names>JM</given-names></name><name><surname>Bhakta</surname><given-names>S</given-names></name><name><surname>Noble</surname><given-names>ME</given-names></name><name><surname>Sim</surname><given-names>E</given-names></name></person-group><article-title>Expression, purification, characterization and structure of Pseudomonas aeruginosa arylamine N-acetyltransferase</article-title><source>Biochem J</source><year>2005</year><volume>385</volume><fpage>605</fpage><lpage>612</lpage><pub-id pub-id-type="pmid">15447630</pub-id><pub-id pub-id-type="doi">10.1042/BJ20041330</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sandy</surname><given-names>J</given-names></name><name><surname>Mushtaq</surname><given-names>A</given-names></name><name><surname>Kawamura</surname><given-names>A</given-names></name><name><surname>Sinclair</surname><given-names>J</given-names></name><name><surname>Sim</surname><given-names>E</given-names></name><name><surname>Noble</surname><given-names>M</given-names></name></person-group><article-title>The structure of arylamine N-acetyltransferase from Mycobacterium smegmatis - an enzyme which inactivates the anti-tubercular drug, isoniazid</article-title><source>J Mol Biol</source><year>2002</year><volume>318</volume><fpage>1071</fpage><lpage>1083</lpage><pub-id pub-id-type="pmid">12054803</pub-id><pub-id pub-id-type="doi">10.1016/S0022-2836(02)00141-9</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sinclair</surname><given-names>JC</given-names></name><name><surname>Sandy</surname><given-names>J</given-names></name><name><surname>Delgoda</surname><given-names>R</given-names></name><name><surname>Sim</surname><given-names>E</given-names></name><name><surname>Noble</surname><given-names>ME</given-names></name></person-group><article-title>Structure of arylamine N-acetyltransferase reveals a catalytic triad</article-title><source>Nat Struct Biol</source><year>2000</year><volume>7</volume><fpage>560</fpage><lpage>564</lpage><pub-id pub-id-type="pmid">10876241</pub-id><pub-id pub-id-type="doi">10.1038/76783</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sandy</surname><given-names>J</given-names></name><name><surname>Mushtaq</surname><given-names>A</given-names></name><name><surname>Holton</surname><given-names>SJ</given-names></name><name><surname>Schartau</surname><given-names>P</given-names></name><name><surname>Noble</surname><given-names>ME</given-names></name><name><surname>Sim</surname><given-names>E</given-names></name></person-group><article-title>Investigation of the catalytic triad of arylamine N-acetyltransferases: essential residues required for acetyl transfer to arylamines</article-title><source>Biochem J</source><year>2005</year><volume>390</volume><fpage>115</fpage><lpage>123</lpage><pub-id pub-id-type="pmid">15869465</pub-id><pub-id pub-id-type="doi">10.1042/BJ20050277</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brooke</surname><given-names>EW</given-names></name><name><surname>Davies</surname><given-names>SG</given-names></name><name><surname>Mulvaney</surname><given-names>AW</given-names></name><name><surname>Pompeo</surname><given-names>F</given-names></name><name><surname>Sim</surname><given-names>E</given-names></name><name><surname>Vickers</surname><given-names>RJ</given-names></name></person-group><article-title>An approach to identifying novel substrates of bacterial arylamine N-acetyltransferases</article-title><source>Bioorg Med Chem</source><year>2003</year><volume>11</volume><fpage>1227</fpage><lpage>1234</lpage><pub-id pub-id-type="pmid">12628650</pub-id><pub-id pub-id-type="doi">10.1016/S0968-0896(02)00642-9</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Riddles</surname><given-names>PW</given-names></name><name><surname>Blakeley</surname><given-names>RL</given-names></name><name><surname>Zerner</surname><given-names>B</given-names></name></person-group><article-title>Reassessment of Ellman's reagent</article-title><source>Methods Enzymol</source><year>1983</year><volume>91</volume><fpage>49</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">6855597</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brooke</surname><given-names>EW</given-names></name><name><surname>Davies</surname><given-names>SG</given-names></name><name><surname>Mulvaney</surname><given-names>AW</given-names></name><name><surname>Okada</surname><given-names>M</given-names></name><name><surname>Pompeo</surname><given-names>F</given-names></name><name><surname>Sim</surname><given-names>E</given-names></name><name><surname>Vickers</surname><given-names>RJ</given-names></name><name><surname>Westwood</surname><given-names>IM</given-names></name></person-group><article-title>Synthesis and in vitro evaluation of novel small molecule inhibitors of bacterial arylamine N-acetyltransferases (NATs)</article-title><source>Bioorg Med Chem Lett</source><year>2003</year><volume>13</volume><fpage>2527</fpage><lpage>2530</lpage><pub-id pub-id-type="pmid">12852958</pub-id><pub-id pub-id-type="doi">10.1016/S0960-894X(03)00484-0</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hein</surname><given-names>DW</given-names></name></person-group><article-title>Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis</article-title><source>Mutat Res</source><year>2002</year><volume>506-507</volume><fpage>65</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">12351146</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kadlubar</surname><given-names>FF</given-names></name><name><surname>Badawi</surname><given-names>AF</given-names></name></person-group><article-title>Genetic susceptibility and carcinogen-DNA adduct formation in human urinary bladder carcinogenesis</article-title><source>Toxicol Lett</source><year>1995</year><volume>82-83</volume><fpage>627</fpage><lpage>632</lpage><pub-id pub-id-type="pmid">8597119</pub-id><pub-id pub-id-type="doi">10.1016/0378-4274(95)03507-9</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hanna</surname><given-names>PE</given-names></name></person-group><article-title>N-acetyltransferases, O-acetyltransferases, and N,O-acetyltransferases: enzymology and bioactivation</article-title><source>Adv Pharmacol</source><year>1994</year><volume>27</volume><fpage>401</fpage><lpage>430</lpage><pub-id pub-id-type="pmid">8068562</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Minchin</surname><given-names>RF</given-names></name></person-group><article-title>Acetylation of p-aminobenzoylglutamate, a folic acid catabolite, by recombinant human arylamine N-acetyltransferase and U937 cells</article-title><source>Biochem J</source><year>1995</year><volume>307</volume><fpage>1</fpage><lpage>3</lpage><pub-id pub-id-type="pmid">7717963</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>N</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>F</given-names></name><name><surname>Wagner</surname><given-names>CR</given-names></name><name><surname>Hanna</surname><given-names>PE</given-names></name><name><surname>Walters</surname><given-names>KJ</given-names></name></person-group><article-title>NMR-based model reveals the structural determinants of mammalian arylamine N-acetyltransferase substrate specificity</article-title><source>J Mol Biol</source><year>2006</year><volume>363</volume><fpage>188</fpage><lpage>200</lpage><pub-id pub-id-type="pmid">16959263</pub-id><pub-id pub-id-type="doi">10.1016/j.jmb.2006.08.026</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rodrigues-Lima</surname><given-names>F</given-names></name><name><surname>Delomenie</surname><given-names>C</given-names></name><name><surname>Goodfellow</surname><given-names>GH</given-names></name><name><surname>Grant</surname><given-names>DM</given-names></name><name><surname>Dupret</surname><given-names>JM</given-names></name></person-group><article-title>Homology modelling and structural analysis of human arylamine N-acetyltransferase NAT1: evidence for the conservation of a cysteine protease catalytic domain and an active-site loop</article-title><source>Biochem J</source><year>2001</year><volume>356</volume><fpage>327</fpage><lpage>334</lpage><pub-id pub-id-type="pmid">11368758</pub-id><pub-id pub-id-type="doi">10.1042/0264-6021:3560327</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rodrigues-Lima</surname><given-names>F</given-names></name><name><surname>Dupret</surname><given-names>JM</given-names></name></person-group><article-title>3D model of human arylamine N-acetyltransferase 2: structural basis of the slow acetylator phenotype of the R64Q variant and analysis of the active-site loop</article-title><source>Biochem Biophys Res Commun</source><year>2002</year><volume>291</volume><fpage>116</fpage><lpage>123</lpage><pub-id pub-id-type="pmid">11829470</pub-id><pub-id pub-id-type="doi">10.1006/bbrc.2002.6414</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kawamura</surname><given-names>A</given-names></name><name><surname>Graham</surname><given-names>J</given-names></name><name><surname>Mushtaq</surname><given-names>A</given-names></name><name><surname>Tsiftsoglou</surname><given-names>SA</given-names></name><name><surname>Vath</surname><given-names>GM</given-names></name><name><surname>Hanna</surname><given-names>PE</given-names></name><name><surname>Wagner</surname><given-names>CR</given-names></name><name><surname>Sim</surname><given-names>E</given-names></name></person-group><article-title>Eukaryotic arylamine N-acetyltransferase. Investigation of substrate specificity by high-throughput screening</article-title><source>Biochem Pharmacol</source><year>2005</year><volume>69</volume><fpage>347</fpage><lpage>359</lpage><pub-id pub-id-type="pmid">15627487</pub-id><pub-id pub-id-type="doi">10.1016/j.bcp.2004.09.014</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Payton</surname><given-names>M</given-names></name><name><surname>Mushtaq</surname><given-names>A</given-names></name><name><surname>Yu</surname><given-names>TW</given-names></name><name><surname>Wu</surname><given-names>LJ</given-names></name><name><surname>Sinclair</surname><given-names>J</given-names></name><name><surname>Sim</surname><given-names>E</given-names></name></person-group><article-title>Eubacterial arylamine N-acetyltransferases - identification and comparison of 18 members of the protein family with conserved active site cysteine, histidine and aspartate residues</article-title><source>Microbiology</source><year>2001</year><volume>147</volume><fpage>1137</fpage><lpage>1147</lpage><pub-id pub-id-type="pmid">11320117</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Riddle</surname><given-names>B</given-names></name><name><surname>Jencks</surname><given-names>WP</given-names></name></person-group><article-title>Acetyl-coenzyme A: arylamine N-acetyltransferase. Role of the acetyl-enzyme intermediate and the effects of substituents on the rate</article-title><source>J Biol Chem</source><year>1971</year><volume>246</volume><fpage>3250</fpage><lpage>3258</lpage><pub-id pub-id-type="pmid">5103348</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Andres</surname><given-names>HH</given-names></name><name><surname>Klem</surname><given-names>AJ</given-names></name><name><surname>Szabo</surname><given-names>SM</given-names></name><name><surname>Weber</surname><given-names>WW</given-names></name></person-group><article-title>New spectrophotometric and radiochemical assays for acetyl-CoA: arylamine N-acetyltransferase applicable to a variety of arylamines</article-title><source>Anal Biochem</source><year>1985</year><volume>145</volume><fpage>367</fpage><lpage>375</lpage><pub-id pub-id-type="pmid">4014668</pub-id><pub-id pub-id-type="doi">10.1016/0003-2697(85)90376-8</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jenne</surname><given-names>JW</given-names></name><name><surname>Boyer</surname><given-names>PD</given-names></name></person-group><article-title>Kinetic characteristics of the acetylation of isoniazid and p-aminosalicylic acid by a liver-enzyme preparation</article-title><source>Biochim Biophys Acta</source><year>1962</year><volume>65</volume><fpage>121</fpage><lpage>127</lpage><pub-id pub-id-type="pmid">14029035</pub-id><pub-id pub-id-type="doi">10.1016/0006-3002(62)90155-5</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Weber</surname><given-names>WW</given-names></name><name><surname>Cohen</surname><given-names>SN</given-names></name></person-group><article-title>N-acetylation of drugs: isolation and properties of an N-acetyltransferase from rabbit liver</article-title><source>Mol Pharmacol</source><year>1967</year><volume>3</volume><fpage>266</fpage><lpage>273</lpage><pub-id pub-id-type="pmid">6037685</pub-id></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cleland</surname><given-names>WW</given-names></name></person-group><article-title>The kinetics of enzyme-catalyzed reactions with two or more substrates or products. I. Nomenclature and rate equations</article-title><source>Biochim Biophys Acta</source><year>1963</year><volume>67</volume><fpage>104</fpage><lpage>137</lpage><pub-id pub-id-type="pmid">14021667</pub-id><pub-id pub-id-type="doi">10.1016/0006-3002(63)91800-6</pub-id></citation></ref><ref id="B28"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Andres</surname><given-names>HH</given-names></name><name><surname>Klem</surname><given-names>AJ</given-names></name><name><surname>Schopfer</surname><given-names>LM</given-names></name><name><surname>Harrison</surname><given-names>JK</given-names></name><name><surname>Weber</surname><given-names>WW</given-names></name></person-group><article-title>On the active site of liver acetyl-CoA. Arylamine N-acetyltransferase from rapid acetylator rabbits (III/J)</article-title><source>J Biol Chem</source><year>1988</year><volume>263</volume><fpage>7521</fpage><lpage>7527</lpage><pub-id pub-id-type="pmid">2897358</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Andres</surname><given-names>HH</given-names></name><name><surname>Kolb</surname><given-names>HJ</given-names></name><name><surname>Schreiber</surname><given-names>RJ</given-names></name><name><surname>Weiss</surname><given-names>L</given-names></name></person-group><article-title>Characterization of the active site, substrate specificity and kinetic properties of acetyl-CoA:arylamine N-acetyltransferase from pigeon liver</article-title><source>Biochim Biophys Acta</source><year>1983</year><volume>746</volume><fpage>193</fpage><lpage>201</lpage><pub-id pub-id-type="pmid">6882770</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Andres</surname><given-names>HH</given-names></name><name><surname>Vogel</surname><given-names>RS</given-names></name><name><surname>Tarr</surname><given-names>GE</given-names></name><name><surname>Johnson</surname><given-names>L</given-names></name><name><surname>Weber</surname><given-names>WW</given-names></name></person-group><article-title>Purification, physicochemical, and kinetic properties of liver acetyl-CoA:arylamine N-acetyltransferase from rapid acetylator rabbits</article-title><source>Mol Pharmacol</source><year>1987</year><volume>31</volume><fpage>446</fpage><lpage>456</lpage><pub-id pub-id-type="pmid">3574290</pub-id></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jenne</surname><given-names>JW</given-names></name></person-group><article-title>Partial purification and properties of the isoniazid transacetylase in human liver: its relationship to the acetylation of p-aminosalicylic acid</article-title><source>J Clin Invest</source><year>1965</year><volume>44</volume><fpage>1992</fpage><lpage>2002</lpage><pub-id pub-id-type="pmid">5851956</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jencks</surname><given-names>WP</given-names></name><name><surname>Gresser</surname><given-names>M</given-names></name><name><surname>Valenzuela</surname><given-names>MS</given-names></name><name><surname>Huneeus</surname><given-names>FC</given-names></name></person-group><article-title>Acetyl Coenzyme A : Arylamine Acetyltransferase (Measurement of the steady state concentration of the acetyl-enzyme intermediate)</article-title><source>J Biol Chem</source><year>1972</year><volume>247</volume><fpage>3756</fpage><lpage>3760</lpage><pub-id pub-id-type="pmid">5064220</pub-id></citation></ref><ref id="B33"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hickman</surname><given-names>D</given-names></name><name><surname>Palamanda</surname><given-names>JR</given-names></name><name><surname>Unadkat</surname><given-names>JD</given-names></name><name><surname>Sim</surname><given-names>E</given-names></name></person-group><article-title>Enzyme kinetic properties of human recombinant arylamine N-acetyltransferase 2 allotypic variants expressed in Escherichia coli</article-title><source>Biochem Pharmacol</source><year>1995</year><volume>50</volume><fpage>697</fpage><lpage>703</lpage><pub-id pub-id-type="pmid">7669073</pub-id><pub-id pub-id-type="doi">10.1016/0006-2952(95)00182-Y</pub-id></citation></ref><ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Vath</surname><given-names>GM</given-names></name><name><surname>Gleason</surname><given-names>KJ</given-names></name><name><surname>Hanna</surname><given-names>PE</given-names></name><name><surname>Wagner</surname><given-names>CR</given-names></name></person-group><article-title>Probing the mechanism of hamster arylamine N-acetyltransferase 2 acetylation by active site modification, site-directed mutagenesis, and pre-steady state and steady state kinetic studies</article-title><source>Biochemistry</source><year>2004</year><volume>43</volume><fpage>8234</fpage><lpage>8246</lpage><pub-id pub-id-type="pmid">15209520</pub-id><pub-id pub-id-type="doi">10.1021/bi0497244</pub-id></citation></ref><ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Hanna</surname><given-names>PE</given-names></name><name><surname>Wagner</surname><given-names>CR</given-names></name></person-group><article-title>Catalytic mechanism of hamster arylamine N-acetyltransferase 2</article-title><source>Biochemistry</source><year>2005</year><volume>44</volume><fpage>11295</fpage><lpage>306</lpage><pub-id pub-id-type="pmid">16101314</pub-id><pub-id pub-id-type="doi">10.1021/bi047564q</pub-id></citation></ref><ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bravo</surname><given-names>IG</given-names></name><name><surname>Busto</surname><given-names>F</given-names></name><name><surname>De Arriaga</surname><given-names>D</given-names></name><name><surname>Ferrero</surname><given-names>MA</given-names></name><name><surname>Rodriguez-Aparicio</surname><given-names>LB</given-names></name><name><surname>Martinez-Blanco</surname><given-names>H</given-names></name><name><surname>Reglero</surname><given-names>A</given-names></name></person-group><article-title>A normalized plot as a novel and time-saving tool in complex enzyme kinetic analysis</article-title><source>Biochem J</source><year>2001</year><volume>358</volume><fpage>573</fpage><lpage>583</lpage><pub-id pub-id-type="pmid">11577687</pub-id></citation></ref><ref id="B37"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mannervik</surname><given-names>B</given-names></name></person-group><article-title>Regression analysis, experimental error, and statistical criteria in the design and analysis of experiments for discrimination between rival kinetic models</article-title><source>Methods Enzymol</source><year>1982</year><volume>87</volume><fpage>370</fpage><lpage>390</lpage><pub-id pub-id-type="pmid">7176922</pub-id></citation></ref><ref id="B38"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mushtaq</surname><given-names>A</given-names></name><name><surname>Payton</surname><given-names>M</given-names></name><name><surname>Sim</surname><given-names>E</given-names></name></person-group><article-title>The COOH terminus of arylamine N-acetyltransferase from Salmonella typhimurium controls enzymic activity</article-title><source>J Biol Chem</source><year>2002</year><volume>277</volume><fpage>12175</fpage><lpage>12181</lpage><pub-id pub-id-type="pmid">11799105</pub-id><pub-id pub-id-type="doi">10.1074/jbc.M104365200</pub-id></citation></ref><ref id="B39"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sandy</surname><given-names>J</given-names></name><name><surname>Holton</surname><given-names>S</given-names></name><name><surname>Fullam</surname><given-names>E</given-names></name><name><surname>Sim</surname><given-names>E</given-names></name><name><surname>Noble</surname><given-names>M</given-names></name></person-group><article-title>Binding of the anti-tubercular drug isoniazid to the arylamine N-acetyltransferase protein from Mycobacterium smegmatis</article-title><source>Protein Sci</source><year>2005</year><volume>14</volume><fpage>775</fpage><lpage>782</lpage><pub-id pub-id-type="pmid">15722451</pub-id><pub-id pub-id-type="doi">10.1110/ps.041163505</pub-id></citation></ref><ref id="B40"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Delgoda</surname><given-names>R</given-names></name><name><surname>Lian</surname><given-names>LY</given-names></name><name><surname>Sandy</surname><given-names>J</given-names></name><name><surname>Sim</surname><given-names>E</given-names></name></person-group><article-title>NMR investigation of the catalytic mechanism of arylamine N-acetyltransferase from Salmonella typhimurium</article-title><source>Biochim Biophys Acta</source><year>2003</year><volume>1620</volume><fpage>8</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">12595067</pub-id></citation></ref><ref id="B41"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Delgoda</surname><given-names>R</given-names></name></person-group><article-title>A Study of Arylamine N-acetyltransferase from Salmonella typhimurium</article-title><source>D Phil Thesis</source><year>1999</year><publisher-name>Oxford, University of Oxford</publisher-name></citation></ref><ref id="B42"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Westwood</surname><given-names>IM</given-names></name><name><surname>Kawamura</surname><given-names>A</given-names></name><name><surname>Fullam</surname><given-names>E</given-names></name><name><surname>Russell</surname><given-names>AJ</given-names></name><name><surname>Davies</surname><given-names>SG</given-names></name><name><surname>Sim</surname><given-names>E</given-names></name></person-group><article-title>Structure and mechanism of arylamine N-acetyltransferases</article-title><source>Curr Top Med Chem</source><year>2006</year><volume>6</volume><fpage>1641</fpage><lpage>1654</lpage><pub-id pub-id-type="pmid">16918475</pub-id><pub-id pub-id-type="doi">10.2174/156802606778108979</pub-id></citation></ref><ref id="B43"><citation citation-type="other"><article-title>Expasy ProtParam tool</article-title><ext-link ext-link-type="uri" xlink:href="http://us.expasy.org/tools/protparam.html"/></citation></ref><ref id="B44"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Gasteiger</surname><given-names>E</given-names></name><name><surname>Hoogland</surname><given-names>C</given-names></name><name><surname>Gattiker</surname><given-names>A</given-names></name><name><surname>Duvaud</surname><given-names>A</given-names></name><name><surname>Wilkins</surname><given-names>M</given-names></name><name><surname>Appel</surname><given-names>RD</given-names></name><name><surname>Bairoch</surname><given-names>A</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Walker JM</surname></name></person-group><article-title>Protein Identification and Analysis Tools on the ExPASy Server</article-title><source>The Proteomics Protocols Handbook</source><year>2005</year><publisher-name>Totowa, Humana Press</publisher-name><fpage>571</fpage><lpage>607</lpage></citation></ref><ref id="B45"><citation citation-type="other"><article-title>KyPlot v2.0 beta 13</article-title><ext-link ext-link-type="uri" xlink:href="http://www.woundedmoon.org/win32/kyplot.html"/></citation></ref><ref id="B46"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guex</surname><given-names>N</given-names></name><name><surname>Peitsch</surname><given-names>MC</given-names></name></person-group><article-title>SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling</article-title><source>Electrophoresis</source><year>1997</year><volume>18</volume><fpage>2714</fpage><lpage>2723</lpage><pub-id pub-id-type="pmid">9504803</pub-id><pub-id pub-id-type="doi">10.1002/elps.1150181505</pub-id></citation></ref></ref-list></back></article> 